000074026012/31Q2false2026512,946,359P1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesvtr:propertyvtr:segmentxbrli:purevtr:boardMembervtr:periodiso4217:CAD00007402602026-01-012026-06-3000007402602026-07-2800007402602026-06-3000007402602025-12-310000740260vtr:TripleNetLeasedPropertiesMember2026-04-012026-06-300000740260vtr:TripleNetLeasedPropertiesMember2025-04-012025-06-300000740260vtr:TripleNetLeasedPropertiesMember2026-01-012026-06-300000740260vtr:TripleNetLeasedPropertiesMember2025-01-012025-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMember2026-04-012026-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMember2025-04-012025-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMember2026-01-012026-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMember2025-01-012025-06-3000007402602026-04-012026-06-3000007402602025-04-012025-06-3000007402602025-01-012025-06-300000740260vtr:ResidentFeesandServicesMember2026-04-012026-06-300000740260vtr:ResidentFeesandServicesMember2025-04-012025-06-300000740260vtr:ResidentFeesandServicesMember2026-01-012026-06-300000740260vtr:ResidentFeesandServicesMember2025-01-012025-06-300000740260vtr:ThirdPartyCapitalManagementMember2026-04-012026-06-300000740260vtr:ThirdPartyCapitalManagementMember2025-04-012025-06-300000740260vtr:ThirdPartyCapitalManagementMember2026-01-012026-06-300000740260vtr:ThirdPartyCapitalManagementMember2025-01-012025-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMember2026-04-012026-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMember2025-04-012025-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMember2026-01-012026-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMember2025-01-012025-06-300000740260us-gaap:NoncontrollingInterestMember2026-01-012026-06-300000740260us-gaap:RetainedEarningsMember2026-04-012026-06-300000740260us-gaap:RetainedEarningsMember2026-01-012026-06-300000740260us-gaap:CommonStockMember2026-03-310000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-03-310000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000740260us-gaap:RetainedEarningsMember2026-03-310000740260us-gaap:TreasuryStockCommonMember2026-03-310000740260us-gaap:ParentMember2026-03-310000740260us-gaap:NoncontrollingInterestMember2026-03-3100007402602026-03-310000740260us-gaap:CommonStockMember2026-04-012026-06-300000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-04-012026-06-300000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300000740260us-gaap:TreasuryStockCommonMember2026-04-012026-06-300000740260us-gaap:ParentMember2026-04-012026-06-300000740260us-gaap:NoncontrollingInterestMember2026-04-012026-06-300000740260us-gaap:CommonStockMember2026-06-300000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-06-300000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300000740260us-gaap:RetainedEarningsMember2026-06-300000740260us-gaap:TreasuryStockCommonMember2026-06-300000740260us-gaap:ParentMember2026-06-300000740260us-gaap:NoncontrollingInterestMember2026-06-300000740260us-gaap:CommonStockMember2025-03-310000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-03-310000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000740260us-gaap:RetainedEarningsMember2025-03-310000740260us-gaap:TreasuryStockCommonMember2025-03-310000740260us-gaap:ParentMember2025-03-310000740260us-gaap:NoncontrollingInterestMember2025-03-3100007402602025-03-310000740260us-gaap:CommonStockMember2025-04-012025-06-300000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-04-012025-06-300000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000740260us-gaap:RetainedEarningsMember2025-04-012025-06-300000740260us-gaap:TreasuryStockCommonMember2025-04-012025-06-300000740260us-gaap:ParentMember2025-04-012025-06-300000740260us-gaap:NoncontrollingInterestMember2025-04-012025-06-300000740260us-gaap:CommonStockMember2025-06-300000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-06-300000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000740260us-gaap:RetainedEarningsMember2025-06-300000740260us-gaap:TreasuryStockCommonMember2025-06-300000740260us-gaap:ParentMember2025-06-300000740260us-gaap:NoncontrollingInterestMember2025-06-3000007402602025-06-300000740260us-gaap:CommonStockMember2025-12-310000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-12-310000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000740260us-gaap:RetainedEarningsMember2025-12-310000740260us-gaap:TreasuryStockCommonMember2025-12-310000740260us-gaap:ParentMember2025-12-310000740260us-gaap:NoncontrollingInterestMember2025-12-310000740260us-gaap:CommonStockMember2026-01-012026-06-300000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-01-012026-06-300000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-06-300000740260us-gaap:TreasuryStockCommonMember2026-01-012026-06-300000740260us-gaap:ParentMember2026-01-012026-06-300000740260us-gaap:CommonStockMember2024-12-310000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-12-310000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000740260us-gaap:RetainedEarningsMember2024-12-310000740260us-gaap:TreasuryStockCommonMember2024-12-310000740260us-gaap:ParentMember2024-12-310000740260us-gaap:NoncontrollingInterestMember2024-12-3100007402602024-12-310000740260us-gaap:CommonStockMember2025-01-012025-06-300000740260us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-01-012025-06-300000740260us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300000740260us-gaap:RetainedEarningsMember2025-01-012025-06-300000740260us-gaap:TreasuryStockCommonMember2025-01-012025-06-300000740260us-gaap:ParentMember2025-01-012025-06-300000740260us-gaap:NoncontrollingInterestMember2025-01-012025-06-300000740260us-gaap:OperatingSegmentsMember2026-06-300000740260us-gaap:CorporateNonSegmentMember2026-06-300000740260us-gaap:OperatingSegmentsMembervtr:SeniorHousingOperatingPortfolioSHOPMember2026-01-012026-06-300000740260us-gaap:OperatingSegmentsMembervtr:SeniorsHousingCommunitiesManagedbyIndependentOperatorsMember2026-06-300000740260us-gaap:OperatingSegmentsMembervtr:OutpatientMedicalAndResearchPortfolioMember2026-01-012026-06-300000740260us-gaap:OperatingSegmentsMembervtr:OutpatientMedicalAndResearchPortfolioMember2026-06-300000740260us-gaap:OperatingSegmentsMembervtr:TripleNetLeasedPropertiesMember2026-01-012026-06-300000740260us-gaap:OperatingSegmentsMembervtr:TripleNetLeasedPropertiesMember2026-06-300000740260us-gaap:CorporateNonSegmentMember2026-01-012026-06-300000740260us-gaap:VariableInterestEntityPrimaryBeneficiaryMembervtr:FondsImmobilierGroupeMauriceSECMember2026-06-300000740260us-gaap:VariableInterestEntityPrimaryBeneficiaryMembervtr:FondsImmobilierGroupeMauriceSECMember2025-12-310000740260us-gaap:VariableInterestEntityPrimaryBeneficiaryMembervtr:NhppmblpMember2026-06-300000740260us-gaap:VariableInterestEntityPrimaryBeneficiaryMembervtr:NhppmblpMember2025-12-310000740260us-gaap:VariableInterestEntityPrimaryBeneficiaryMembervtr:OtherIdentifiedVIEsMember2026-06-300000740260us-gaap:VariableInterestEntityPrimaryBeneficiaryMembervtr:OtherIdentifiedVIEsMember2025-12-310000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMemberus-gaap:SalesRevenueNetMember2026-01-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMemberus-gaap:SalesRevenueNetMember2025-01-012025-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMemberus-gaap:SalesRevenueNetMember2026-01-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMemberus-gaap:SalesRevenueNetMember2025-01-012025-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMembervtr:NetOperatingIncomeMember2026-04-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMembervtr:NetOperatingIncomeMember2025-04-012025-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMembervtr:NetOperatingIncomeMember2026-01-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:ArdentMembervtr:NetOperatingIncomeMember2025-01-012025-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMembervtr:NetOperatingIncomeMember2026-04-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMembervtr:NetOperatingIncomeMember2025-04-012025-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMembervtr:NetOperatingIncomeMember2026-01-012026-06-300000740260us-gaap:CustomerConcentrationRiskMembervtr:KindredMembervtr:NetOperatingIncomeMember2025-01-012025-06-3000007402602026-06-012026-06-300000740260vtr:SeniorHousingCommunityMembervtr:SeniorHousingOperatingPortfolioSHOPMember2026-01-012026-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMember2026-01-012026-06-300000740260us-gaap:SubsequentEventMembervtr:SeniorHousingOperatingPortfolioSHOPMembervtr:SeniorHousingCommunityMember2026-07-012026-07-280000740260us-gaap:SubsequentEventMembervtr:SeniorHousingOperatingPortfolioSHOPMember2026-07-012026-07-280000740260vtr:DispositionsMembervtr:SeniorHousingOperatingPortfolioSHOPMember2026-06-300000740260vtr:DispositionsMembervtr:OutpatientMedicalAndResearchPortfolioMember2026-06-300000740260vtr:DispositionsMembervtr:TripleNetLeasedPropertiesMember2026-06-300000740260vtr:DispositionsMember2026-01-012026-06-300000740260vtr:DispositionsMembervtr:OutpatientMedicalAndResearchPortfolioMember2025-06-300000740260vtr:DispositionsMembervtr:OutpatientMedicalAndResearchPortfolioMember2025-06-012025-06-300000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembervtr:SeniorHousingOperatingPortfolioSHOPMember2026-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMember2026-06-300000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembervtr:SeniorHousingOperatingPortfolioSHOPMember2025-12-310000740260vtr:SeniorHousingOperatingPortfolioSHOPMember2025-12-310000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembervtr:OutpatientMedicalAndResearchPortfolioMember2026-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMember2026-06-300000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembervtr:OutpatientMedicalAndResearchPortfolioMember2025-12-310000740260vtr:OutpatientMedicalAndResearchPortfolioMember2025-12-310000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembervtr:TripleNetLeasedPropertiesMember2026-06-300000740260vtr:TripleNetLeasedPropertiesMember2026-06-300000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembervtr:TripleNetLeasedPropertiesMember2025-12-310000740260vtr:TripleNetLeasedPropertiesMember2025-12-310000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2026-06-300000740260us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2025-12-310000740260us-gaap:DepreciationAndAmortization2026-04-012026-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:DepreciationAndAmortization2026-04-012026-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:DepreciationAndAmortization2026-04-012026-06-300000740260vtr:TripleNetLeasedPropertiesMemberus-gaap:DepreciationAndAmortization2026-04-012026-06-300000740260us-gaap:DepreciationAndAmortization2026-01-012026-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:DepreciationAndAmortization2026-01-012026-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:DepreciationAndAmortization2026-01-012026-06-300000740260vtr:TripleNetLeasedPropertiesMemberus-gaap:DepreciationAndAmortization2026-01-012026-06-300000740260us-gaap:DepreciationAndAmortization2025-04-012025-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:DepreciationAndAmortization2025-04-012025-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:DepreciationAndAmortization2025-04-012025-06-300000740260us-gaap:DepreciationAndAmortization2025-01-012025-06-300000740260vtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:DepreciationAndAmortization2025-01-012025-06-300000740260vtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:DepreciationAndAmortization2025-01-012025-06-300000740260vtr:TripleNetLeasedPropertiesMemberus-gaap:DepreciationAndAmortization2025-01-012025-06-300000740260vtr:SecuredLoansReceivableAndInvestmentsMembervtr:ScionMember2026-06-300000740260vtr:SecuredLoansReceivableAndInvestmentsMember2026-06-300000740260vtr:NonMortgageLoanReceivableMember2026-06-300000740260vtr:SecuredLoansReceivableAndInvestmentsMember2025-12-310000740260vtr:NonMortgageLoanReceivableMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembervtr:TheFundMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembervtr:TheFundMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembervtr:VTRAZJVMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembervtr:VTRAZJVMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembervtr:RIJVMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembervtr:RIJVMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembervtr:VentasInvestmentManagementPlatformVIMMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembervtr:VentasInvestmentManagementPlatformVIMMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembervtr:AtriumHealthAndWakeForestJointVentureMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembervtr:AtriumHealthAndWakeForestJointVentureMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembersrt:MinimumMembervtr:OtherEquityMethodInvestmentsMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembersrt:MaximumMembervtr:OtherEquityMethodInvestmentsMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembersrt:MinimumMembervtr:OtherEquityMethodInvestmentsMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembersrt:MaximumMembervtr:OtherEquityMethodInvestmentsMember2025-12-310000740260us-gaap:UnconsolidatedPropertiesMembervtr:OtherEquityMethodInvestmentsMember2026-06-300000740260us-gaap:UnconsolidatedPropertiesMembervtr:OtherEquityMethodInvestmentsMember2025-12-310000740260vtr:VentasFundMembervtr:SeniorHousingCommunityMember2026-01-012026-06-300000740260vtr:VentasFundMember2026-01-012026-06-300000740260vtr:PensionFundJointVentureMembervtr:SeniorHousingCommunitiesMember2026-06-300000740260vtr:PensionFundJointVentureMembervtr:SeniorHousingCommunitiesMember2026-01-012026-06-300000740260us-gaap:SubsequentEventMembervtr:VentasFundMembervtr:SeniorHousingCommunityMember2026-07-012026-07-280000740260us-gaap:SubsequentEventMembervtr:VentasFundMember2026-07-012026-07-280000740260us-gaap:ManagementServiceMember2026-04-012026-06-300000740260us-gaap:ManagementServiceMember2025-04-012025-06-300000740260us-gaap:ManagementServiceMember2025-01-012025-06-300000740260us-gaap:ManagementServiceMember2026-01-012026-06-300000740260vtr:AtriaMember2026-06-300000740260vtr:ArdentMember2026-06-300000740260us-gaap:AboveMarketLeasesMember2026-06-300000740260us-gaap:AboveMarketLeasesMember2025-12-310000740260vtr:LeasesAcquiredInPlaceAndOtherLeaseIntangiblesMember2026-06-300000740260vtr:LeasesAcquiredInPlaceAndOtherLeaseIntangiblesMember2025-12-310000740260us-gaap:OtherIntangibleAssetsMember2026-06-300000740260us-gaap:OtherIntangibleAssetsMember2025-12-3100007402602026-01-012026-03-310000740260vtr:KindredMember2026-06-300000740260us-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2026-06-300000740260us-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2025-12-310000740260vtr:A4.125SeniorNotesdue2026Member2026-06-300000740260vtr:A4.125SeniorNotesdue2026Member2025-12-310000740260vtr:A375ExchangeableSeniorNotesDue2026Member2026-06-300000740260vtr:A375ExchangeableSeniorNotesDue2026Member2025-12-310000740260vtr:A3.25SeniorNotesdue2026Member2026-06-300000740260vtr:A3.25SeniorNotesdue2026Member2025-12-310000740260vtr:UnsecuredTermLoanDueFebruary2027Member2026-06-300000740260vtr:UnsecuredTermLoanDueFebruary2027Member2025-12-310000740260vtr:A245SeniorNotesSeriesGDue2027Member2026-06-300000740260vtr:A245SeniorNotesSeriesGDue2027Member2025-12-310000740260vtr:A3.85SeniorNotesdue2027Member2026-06-300000740260vtr:A3.85SeniorNotesdue2027Member2025-12-310000740260vtr:A4.00SeniorNotesdue2028Member2026-06-300000740260vtr:A4.00SeniorNotesdue2028Member2025-12-310000740260vtr:A5398SeniorNotesSeriesIDue2028Member2026-06-300000740260vtr:A5398SeniorNotesSeriesIDue2028Member2025-12-310000740260vtr:A4.400SeniorNotesdue2029Member2026-06-300000740260vtr:A4.400SeniorNotesdue2029Member2025-12-310000740260vtr:A5.100SeniorNotesSeriesJDue2029Member2024-02-290000740260vtr:A5.100SeniorNotesSeriesJDue2029Member2026-06-300000740260vtr:A5.100SeniorNotesSeriesJDue2029Member2025-12-310000740260vtr:A3.00SeniorNotesdue2030Member2026-06-300000740260vtr:A3.00SeniorNotesdue2030Member2025-12-310000740260vtr:A4.75SeniorNotesdue2030Member2026-06-300000740260vtr:A4.75SeniorNotesdue2030Member2025-12-310000740260vtr:A250SeniorNotesDue2031Member2026-06-300000740260vtr:A250SeniorNotesDue2031Member2025-12-310000740260vtr:A330SeniorNotesSeriesHDue2031Member2026-06-300000740260vtr:A330SeniorNotesSeriesHDue2031Member2025-12-310000740260vtr:UnsecuredTermLoanDueJune2027Member2026-06-300000740260vtr:UnsecuredTermLoanDueJune2027Member2025-12-310000740260vtr:A5.10SeniorNotesDue2032Member2026-06-300000740260vtr:A5.10SeniorNotesDue2032Member2025-12-310000740260vtr:A5.63SeniorNotesDue2034Member2026-06-300000740260vtr:A5.63SeniorNotesDue2034Member2025-12-310000740260vtr:A5.00SeniorNotesDue2035Member2026-06-300000740260vtr:A5.00SeniorNotesDue2035Member2025-12-310000740260vtr:A5.00SeniorNotesDue2036Member2026-06-300000740260vtr:A5.00SeniorNotesDue2036Member2025-12-310000740260vtr:A6.90SeniorNotesdue2037Member2026-06-300000740260vtr:A6.90SeniorNotesdue2037Member2025-12-310000740260vtr:A6.59SeniorNotesdue2038Member2026-06-300000740260vtr:A6.59SeniorNotesdue2038Member2025-12-310000740260vtr:A5.70SeniorNotesdue2043Member2026-06-300000740260vtr:A5.70SeniorNotesdue2043Member2025-12-310000740260vtr:A4375SeniorNotesDue2045Member2026-06-300000740260vtr:A4375SeniorNotesDue2045Member2025-12-310000740260vtr:A4.875SeniorNotesdue2049Member2026-06-300000740260vtr:A4.875SeniorNotesdue2049Member2025-12-310000740260us-gaap:MortgagesMember2026-06-300000740260us-gaap:MortgagesMember2025-12-310000740260us-gaap:UnsecuredDebtMembervtr:BorrowingsoriginallydenominatedinGBPMemberus-gaap:RevolvingCreditFacilityMember2026-06-300000740260us-gaap:UnsecuredDebtMembervtr:BorrowingsoriginallydenominatedinCADMemberus-gaap:RevolvingCreditFacilityMember2026-06-300000740260us-gaap:UnsecuredDebtMembervtr:BorrowingsoriginallydenominatedinGBPMemberus-gaap:RevolvingCreditFacilityMember2025-12-310000740260us-gaap:UnsecuredDebtMembervtr:BorrowingsoriginallydenominatedinCADMemberus-gaap:RevolvingCreditFacilityMember2025-12-310000740260us-gaap:UnsecuredDebtMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-3000007402602026-05-310000740260vtr:VentasRealtyMember2026-06-300000740260vtr:UnsecuredTermLoanDueJune2027Membervtr:VentasRealtyMember2026-01-012026-06-300000740260vtr:UnsecuredTermLoanDueJune2027Membervtr:VentasRealtyMember2026-06-300000740260us-gaap:UnsecuredDebtMemberus-gaap:LetterOfCreditMember2026-06-300000740260us-gaap:UnsecuredDebtMembervtr:CreditAgreementMemberus-gaap:LetterOfCreditMember2026-06-300000740260vtr:A375ExchangeableSeniorNotesDue2026Member2023-06-300000740260vtr:A375ExchangeableSeniorNotesDue2026Member2026-06-012026-06-300000740260vtr:A375ExchangeableSeniorNotesDue2026Member2026-04-012026-06-300000740260vtr:A375ExchangeableSeniorNotesDue2026Member2026-01-012026-06-300000740260vtr:A4.125SeniorNotesdue2026Member2026-01-012026-01-310000740260vtr:A4.125SeniorNotesdue2026Member2026-01-310000740260us-gaap:MortgagesMember2026-01-012026-06-300000740260us-gaap:MortgagesMembervtr:SeniorHousingOperatingPortfolioSHOPMember2026-06-300000740260vtr:SeniorNotesandMortgagesMember2026-06-300000740260us-gaap:LineOfCreditMember2026-06-300000740260vtr:DebtInstrumentPeriodicPaymentMortgagesMember2026-06-300000740260vtr:VariableRateDebtMemberus-gaap:SwapMember2026-06-300000740260vtr:FixedRateDebtMemberus-gaap:SwapMember2026-06-300000740260vtr:FixedRateDebtMembervtr:SwapOneMember2026-06-300000740260vtr:FixedRateDebtMembervtr:SwapTwoMember2026-06-300000740260us-gaap:SwapMember2026-04-012026-06-300000740260us-gaap:SwapMember2026-01-012026-06-300000740260us-gaap:SwapMember2026-06-300000740260us-gaap:CarryingReportedAmountFairValueDisclosureMember2026-06-300000740260us-gaap:EstimateOfFairValueFairValueDisclosureMember2026-06-300000740260us-gaap:CarryingReportedAmountFairValueDisclosureMember2025-12-310000740260us-gaap:EstimateOfFairValueFairValueDisclosureMember2025-12-310000740260us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommercialMortgageBackedSecuritiesMember2026-06-300000740260us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommercialMortgageBackedSecuritiesMember2026-06-300000740260us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommercialMortgageBackedSecuritiesMember2025-12-310000740260us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommercialMortgageBackedSecuritiesMember2025-12-310000740260us-gaap:CarryingReportedAmountFairValueDisclosureMembervtr:NonMortgageLoanReceivableMember2026-06-300000740260us-gaap:EstimateOfFairValueFairValueDisclosureMembervtr:NonMortgageLoanReceivableMember2026-06-300000740260us-gaap:CarryingReportedAmountFairValueDisclosureMembervtr:NonMortgageLoanReceivableMember2025-12-310000740260us-gaap:EstimateOfFairValueFairValueDisclosureMembervtr:NonMortgageLoanReceivableMember2025-12-310000740260vtr:AtTheMarketProgramMember2026-04-012026-04-300000740260vtr:AtTheMarketProgramMember2026-05-012026-05-310000740260vtr:AtTheMarketProgramMember2026-01-012026-06-300000740260vtr:AtTheMarketEquityOfferingProgramForwardSalesAgreementMember2026-04-012026-06-300000740260vtr:AtTheMarketEquityOfferingProgramSettledForwardSalesAgreementMember2026-04-012026-06-300000740260vtr:AtTheMarketEquityOfferingProgramForwardSalesAgreementMember2026-01-012026-06-300000740260vtr:AtTheMarketEquityOfferingProgramSettledForwardSalesAgreementMember2026-01-012026-06-300000740260vtr:AtTheMarketEquityOfferingProgramUnsettledForwardSalesAgreementMember2026-06-300000740260us-gaap:SubsequentEventMembervtr:AtTheMarketEquityOfferingProgramForwardSalesAgreementMember2026-07-012026-07-280000740260us-gaap:SubsequentEventMembervtr:AtTheMarketEquityOfferingProgramForwardSalesAgreementMember2026-07-280000740260us-gaap:SubsequentEventMembervtr:AtTheMarketEquityOfferingProgramUnsettledForwardSalesAgreementMember2026-07-280000740260srt:MinimumMember2026-06-300000740260srt:MaximumMember2026-06-300000740260us-gaap:OperatingSegmentsMembervtr:SeniorHousingOperatingPortfolioSHOPMember2026-04-012026-06-300000740260us-gaap:OperatingSegmentsMembervtr:OutpatientMedicalAndResearchPortfolioMember2026-04-012026-06-300000740260us-gaap:OperatingSegmentsMembervtr:TripleNetLeasedPropertiesMember2026-04-012026-06-300000740260us-gaap:CorporateNonSegmentMember2026-04-012026-06-300000740260vtr:ResidentFeesandServicesMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000740260vtr:ResidentFeesandServicesMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000740260vtr:ResidentFeesandServicesMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000740260vtr:ResidentFeesandServicesMemberus-gaap:CorporateNonSegmentMember2026-04-012026-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2026-04-012026-06-300000740260vtr:ThirdPartyCapitalManagementMemberus-gaap:CorporateNonSegmentMember2026-04-012026-06-300000740260us-gaap:OperatingSegmentsMembervtr:SeniorHousingOperatingPortfolioSHOPMember2025-04-012025-06-300000740260us-gaap:OperatingSegmentsMembervtr:OutpatientMedicalAndResearchPortfolioMember2025-04-012025-06-300000740260us-gaap:OperatingSegmentsMembervtr:TripleNetLeasedPropertiesMember2025-04-012025-06-300000740260us-gaap:CorporateNonSegmentMember2025-04-012025-06-300000740260vtr:ResidentFeesandServicesMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000740260vtr:ResidentFeesandServicesMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000740260vtr:ResidentFeesandServicesMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000740260vtr:ResidentFeesandServicesMemberus-gaap:CorporateNonSegmentMember2025-04-012025-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2025-04-012025-06-300000740260vtr:ThirdPartyCapitalManagementMemberus-gaap:CorporateNonSegmentMember2025-04-012025-06-300000740260vtr:ResidentFeesandServicesMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000740260vtr:ResidentFeesandServicesMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000740260vtr:ResidentFeesandServicesMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000740260vtr:ResidentFeesandServicesMemberus-gaap:CorporateNonSegmentMember2026-01-012026-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2026-01-012026-06-300000740260vtr:ThirdPartyCapitalManagementMemberus-gaap:CorporateNonSegmentMember2026-01-012026-06-300000740260us-gaap:OperatingSegmentsMembervtr:SeniorHousingOperatingPortfolioSHOPMember2025-01-012025-06-300000740260us-gaap:OperatingSegmentsMembervtr:OutpatientMedicalAndResearchPortfolioMember2025-01-012025-06-300000740260us-gaap:OperatingSegmentsMembervtr:TripleNetLeasedPropertiesMember2025-01-012025-06-300000740260us-gaap:CorporateNonSegmentMember2025-01-012025-06-300000740260vtr:ResidentFeesandServicesMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000740260vtr:ResidentFeesandServicesMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000740260vtr:ResidentFeesandServicesMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000740260vtr:ResidentFeesandServicesMemberus-gaap:CorporateNonSegmentMember2025-01-012025-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:SeniorHousingOperatingPortfolioSHOPMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:OutpatientMedicalAndResearchPortfolioMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000740260vtr:ThirdPartyCapitalManagementMembervtr:TripleNetLeasedPropertiesMemberus-gaap:OperatingSegmentsMember2025-01-012025-06-300000740260vtr:ThirdPartyCapitalManagementMemberus-gaap:CorporateNonSegmentMember2025-01-012025-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2026
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 FOR THE TRANSITION PERIOD FROM____________TO____________
Commission file number: 001-10989
Ventas, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
61-1055020
(State or Other Jurisdiction of Incorporation or Organization)
(I.R.S. Employer Identification No.)
300 North LaSalle Street, Suite 1600
Chicago, Illinois 60654
(Address of Principal Executive Offices)    
(877) 483-6827
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol
Name of Exchange on Which Registered
Common Stock $0.25 par value
VTR
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes     No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company 
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐    No 
As of July 28, 2026, there were 512,946,359 shares of the registrant’s common stock outstanding.
    


VENTAS, INC.
FORM 10-Q
INDEX
 
 
Page
 
Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025
Consolidated Statements of Income for the Three and Six Months Ended June 30, 2026 and 2025
Consolidated Statements of Comprehensive Income for the Three and Six Months Ended June 30, 2026 and 2025
Consolidated Statements of Equity for the Three and Six Months Ended June 30, 2026 and 2025
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 2025
Item 3.
Defaults Upon Senior Securities
Item 4.
Mine Safety Disclosures


PART I—FINANCIAL INFORMATION
ITEM 1.    CONSOLIDATED FINANCIAL STATEMENTS

VENTAS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts, unaudited)
As of June 30, 2026
As of December 31, 2025
Assets
Real estate investments:
 
 
Land and improvements
$
3,260,895 
$
2,962,738 
Buildings and improvements
33,346,737 
30,872,598 
Construction in progress
253,902 
358,811 
Acquired lease intangibles
1,937,522 
1,680,567 
Operating lease assets
316,707 
295,838 
39,115,763 
36,170,552 
Accumulated depreciation and amortization
(12,622,838)
(12,043,619)
Net real estate property
26,492,925 
24,126,933 
Secured loans receivable and investments, net
436,401 
143,913 
Investments in unconsolidated real estate entities
590,630 
617,571 
Net real estate investments
27,519,956 
24,888,417 
Cash and cash equivalents
198,956 
741,067 
Escrow deposits and restricted cash
24,861 
45,070 
Goodwill
1,045,816 
1,046,072 
Assets held for sale
28,744 
42,993 
Deferred income tax assets, net
3,134 
2,797 
Other assets
834,429 
825,529 
Total assets
$
29,655,896 
$
27,591,945 
Liabilities and equity
 
 
Liabilities:
 
Senior notes payable and other debt
$
12,687,789 
$
13,011,016 
Accrued interest payable
142,464 
143,104 
Operating lease liabilities
231,210 
208,602 
Accounts payable and other liabilities
1,349,477 
1,240,820 
Liabilities related to assets held for sale
2,584 
4,032 
Deferred income tax liabilities
30,739 
23,409 
Total liabilities
14,444,263 
14,630,983 
Redeemable OP unitholder and noncontrolling interests
509,069 
375,154 
Commitments and contingencies
Equity:
 
 
Ventas stockholders’ equity:
 
 
Preferred stock, $1.00 par value; 10,000 shares authorized, unissued
 
 
Common stock, $0.25 par value; 1,200,000 shares authorized, 512,946 and 474,926 shares outstanding at June 30, 2026 and December 31, 2025, respectively
128,237 
118,732 
Capital in excess of par value
22,478,217 
19,976,183 
Accumulated other comprehensive loss
(31,510)
(39,851)
Retained earnings (deficit)
(7,925,545)
(7,527,777)
Treasury stock, 0 shares issued
 
(34)
Total Ventas stockholders’ equity
14,649,399 
12,527,253 
Noncontrolling interests
53,165 
58,555 
Total equity
14,702,564 
12,585,808 
Total liabilities and equity
$
29,655,896 
$
27,591,945 
See accompanying notes.
1

VENTAS, INC.
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts, unaudited)
 
For the Three Months Ended June 30,
For the Six Months Ended June 30,
 
2026
2025
2026
2025
Revenues
 
 
Rental income:
 
 
Triple-net leased properties
$
124,856 
$
152,702 
$
247,927 
$
308,815 
Outpatient medical and research portfolio
228,605 
220,814 
458,709 
442,133 
353,461 
373,516 
706,636 
750,948 
Resident fees and services
1,363,498 
1,032,714 
2,656,288 
2,001,618 
Third-party capital management revenues
4,245 
4,397 
8,656 
8,733 
Income from loans and investments
6,632 
4,395 
10,701 
8,719 
Interest and other income
1,778 
5,871 
4,277 
8,949 
Total revenues
1,729,614 
1,420,893 
3,386,558 
2,778,967 
Expenses
 
 
Interest
160,034 
150,298 
316,176 
299,654 
Depreciation and amortization
407,711 
347,719 
790,179 
669,244 
Property-level operating expenses:
Senior housing
959,999 
746,302 
1,878,331 
1,450,702 
Outpatient medical and research portfolio
77,781 
75,001 
158,082 
150,958 
Triple-net leased properties
3,142 
3,966 
6,043 
7,493 
1,040,922 
825,269 
2,042,456 
1,609,153 
Third-party capital management expenses
1,706 
1,627 
3,539 
3,452 
General, administrative and professional fees
46,986 
42,856 
109,732 
96,005 
Loss on extinguishment of debt, net
83 
 
532 
 
Transaction, transition and restructuring costs
13,478 
4,627 
20,137 
10,609 
Other expense
4,454 
5,839 
14,154 
7,251 
Total expenses
1,675,374 
1,378,235 
3,296,905 
2,695,368 
Income before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests
54,240 
42,658 
89,653 
83,599 
Loss from unconsolidated entities
(7,812)
(1,138)
(15,162)
(4,449)
Gain on real estate dispositions
176 
33,816 
15,222 
33,985 
Income tax benefit (expense)
25,618 
(3,874)
41,555 
6,683 
Net income
72,222 
71,462 
131,268 
119,818 
Net income attributable to noncontrolling interests
1,652 
3,198 
4,786 
4,686 
Net income attributable to common stockholders
$
70,570 
$
68,264 
$
126,482 
$
115,132 
Earnings per common share
 
 
Basic:
 
 
Net income
$
0.15 
$
0.16 
$
0.27 
$
0.27 
Net income attributable to common stockholders
0.14 
0.15 
0.26 
0.26 
Diluted:
 
 
 
 
Net income
$
0.15 
$
0.16 
$
0.27 
$
0.26 
Net income attributable to common stockholders
0.14 
0.15 
0.26 
0.25 
See accompanying notes.
2

VENTAS, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands, unaudited)

 
For the Three Months Ended June 30,
For the Six Months Ended June 30,
 
2026
2025
2026
2025
Net income
$
72,222 
$
71,462 
$
131,268 
$
119,818 
Other comprehensive income:
Foreign currency translation gain
4,103 
2,952 
1,734 
10,671 
Unrealized (loss) gain on available for sale securities
(152)
141 
(344)
626 
Unrealized gain (loss) on derivative instruments
826 
(78)
3,925 
(7,829)
Total other comprehensive income
4,777 
3,015 
5,315 
3,468 
Comprehensive income
76,999 
74,477 
136,583 
123,286 
Comprehensive (loss) income attributable to noncontrolling interests
(173)
7,946 
1,760 
8,432 
Comprehensive income attributable to common stockholders
$
77,172 
$
66,531 
$
134,823 
$
114,854 
See accompanying notes.
3

VENTAS, INC.
CONSOLIDATED STATEMENTS OF EQUITY
For the Three Months Ended June 30, 2026 and 2025
(In thousands, except per share amounts, unaudited)

For the Three Months Ended June 30, 2026
Common Stock Par Value
Capital in Excess of Par Value
Accumulated Other Comprehensive (Loss) Income
Retained Earnings (Deficit)
Treasury Stock
Total Ventas Stockholders’ Equity
Noncontrolling Interests
Total Equity
Balance at April 1, 2026
$
121,524 
$
20,768,548 
$
(38,112)
$
(7,726,996)
$
 
13,124,964 
$
57,038 
13,182,002 
Net income
70,570 
70,570 
1,652 
72,222 
Other comprehensive income (loss)
 
 
6,602 
 
 
6,602 
(1,825)
4,777 
Net change in noncontrolling interests
 
(7,754)
 
 
 
(7,754)
(3,700)
(11,454)
Dividends to common stockholders—$0.52 per share
 
45 
 
(269,119)
 
(269,074)
(269,074)
Issuance of common stock for stock plans, restricted stock grants and other
6,713 
1,742,384 
 
 
 
1,749,097 
 
1,749,097 
Adjust redeemable OP unitholder interests to current fair value
 
(24,257)
 
 
 
(24,257)
 
(24,257)
Redemption of OP Units
 
(749)
 
 
 
(749)
 
(749)
Balance at June 30, 2026
$
128,237 
$
22,478,217 
$
(31,510)
$
(7,925,545)
$
 
$
14,649,399 
$
53,165 
$
14,702,564 

For the Three Months Ended June 30, 2025
Common Stock Par Value
Capital in Excess of Par Value
Accumulated Other Comprehensive (Loss) Income
Retained Earnings (Deficit)
Treasury Stock
Total Ventas Stockholders’ Equity
Noncontrolling Interests
Total Equity
Balance at April 1, 2025
$
112,497 
$
18,488,381 
$
(32,070)
$
(7,057,776)
$
(41,475)
$
11,469,557 
$
56,559 
$
11,526,116 
Net income
 
 
 
68,264 
 
68,264 
3,198 
71,462 
Other comprehensive (loss) income
 
 
(1,734)
 
 
(1,734)
4,749 
3,015 
Net change in noncontrolling interests
 
(5,471)
 
 
 
(5,471)
(1,433)
(6,904)
Dividends to common stockholders—$0.48 per share
 
25 
 
(219,191)
 
(219,166)
 
(219,166)
Issuance of common stock for stock plans, restricted stock grants and other
719 
201,539 
 
 
(1,680)
200,578 
 
200,578 
Adjust redeemable OP unitholder interests to current fair value
 
18,749 
 
 
 
18,749 
 
18,749 
Redemption of OP Units
 
(1,389)
 
 
 
(1,389)
 
(1,389)
Balance at June 30, 2025
$
113,216 
$
18,701,834 
$
(33,804)
$
(7,208,703)
$
(43,155)
$
11,529,388 
$
63,073 
$
11,592,461 

See accompanying notes.
4

VENTAS, INC.
CONSOLIDATED STATEMENTS OF EQUITY
For the Six Months Ended June 30, 2026 and 2025
(In thousands, except per share amounts, unaudited)

For the Six Months Ended June 30, 2026
Common Stock Par Value
Capital in Excess of Par Value
Accumulated Other Comprehensive(Loss) Income
Retained Earnings (Deficit)
TreasuryStock
Total Ventas Stockholders’Equity
Noncontrolling Interests
Total Equity
Balance at January 1, 2026
$
118,732 
$
19,976,183 
$
(39,851)
$
(7,527,777)
$
(34)
$
12,527,253 
$
58,555 
$
12,585,808 
Net income
 
 
 
126,482 
126,482 
4,786 
131,268 
Other comprehensive income (loss)
 
 
8,341 
 
8,341 
(3,026)
5,315 
Net change in noncontrolling interests
 
(16,295)
 
 
 
(16,295)
(7,150)
(23,445)
Dividends to common stockholders—$1.04 per share
 
44 
 
(524,250)
 
(524,206)
 
(524,206)
Issuance of common stock for stock plans, restricted stock grants and other
9,505 
2,559,769 
 
 
34 
2,569,308 
 
2,569,308 
Adjust redeemable OP unitholder interests to current fair value
 
(38,331)
 
 
(38,331)
 
(38,331)
Redemption of OP Units
 
(3,153)
 
 
(3,153)
 
(3,153)
Balance at June 30, 2026
$
128,237 
$
22,478,217 
$
(31,510)
$
(7,925,545)
$
 
$
14,649,399 
$
53,165 
$
14,702,564 

For the Six Months Ended June 30, 2025
Common Stock Par Value
Capital in Excess of Par Value
Accumulated Other Comprehensive(Loss) Income
Retained Earnings (Deficit)
TreasuryStock
Total Ventas Stockholders’Equity
Noncontrolling Interests
Total Equity
Balance at January 1, 2025
$
109,119 
$
17,607,482 
$
(33,526)
$
(6,886,653)
$
(25,155)
$
10,771,267 
$
58,329 
$
10,829,596 
Net income
 
 
 
115,132 
 
115,132 
4,686 
119,818 
Other comprehensive (loss) income
 
 
(278)
 
 
(278)
3,746 
3,468 
Net change in noncontrolling interests
 
(2,240)
 
 
 
(2,240)
(3,688)
(5,928)
Dividends to common stockholders—$0.96 per share
 
49 
 
(437,182)
 
(437,133)
 
(437,133)
Issuance of common stock for stock plans, restricted stock grants and other
4,097 
1,114,320 
 
 
(18,000)
1,100,417 
 
1,100,417 
Adjust redeemable OP unitholder interests to current fair value
 
(16,323)
 
 
 
(16,323)
 
(16,323)
Redemption of OP Units
 
(1,454)
 
 
 
(1,454)
 
(1,454)
Balance at June 30, 2025
$
113,216 
$
18,701,834 
$
(33,804)
$
(7,208,703)
$
(43,155)
$
11,529,388 
$
63,073 
$
11,592,461 

See accompanying notes.

5

VENTAS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
 
For the Six Months Ended June 30,
 
2026
2025
Cash flows from operating activities:
 
Net income
$
131,268 
$
119,818 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
790,179 
669,244 
Amortization of deferred revenue and lease intangibles, net
(9,263)
(19,364)
Other non-cash amortization
17,185 
14,059 
Stock-based compensation
30,154 
26,510 
Straight-lining of rental income
(14,113)
(12,547)
Loss on extinguishment of debt, net
532 
 
Gain on real estate dispositions
(15,222)
(33,985)
Gain on real estate loan investments
(11)
 
Income tax benefit
(48,255)
(13,032)
Loss from unconsolidated entities
15,161 
4,449 
Distributions from unconsolidated entities
18,250 
15,026 
Other
3,580 
(2,752)
Changes in operating assets and liabilities:
Decrease in other assets
13,304 
51,523 
Decrease in accrued interest payable
(1,407)
(13,893)
Increase (decrease) in accounts payable and other liabilities
19,814 
(8,574)
Net cash provided by operating activities
951,156 
796,482 
Cash flows from investing activities:
 
 
Net investment in real estate property
(2,448,803)
(960,727)
Investment in loans receivable
(301,457)
(581)
Proceeds from real estate disposals
52,574 
149,014 
Proceeds from loans receivable
7,146 
7,848 
Redevelopment and development project expenditures
(149,676)
(125,538)
Other capital expenditures
(174,797)
(133,977)
Distributions from unconsolidated entities
11,212 
 
Investment in unconsolidated entities
(18,436)
(24,855)
Insurance proceeds for property damage claims
2,932 
652 
Net cash used in investing activities
(3,019,305)
(1,088,164)
Cash flows from financing activities:
 
 
Net change in borrowings under revolving credit facilities
 
(5,422)
Net change in borrowings under commercial paper program
264,971 
 
Proceeds from debt
891,730 
587,199 
Repayment of debt
(1,678,830)
(1,209,580)
Payment of deferred financing costs
(7,306)
(8,908)
Issuance of common stock, net
2,548,239 
1,064,749 
Cash distributions to common stockholders
(483,538)
(415,989)
Cash distributions to redeemable OP unitholders
(3,310)
(3,127)
Cash issued for redemption of OP Units
(2,844)
(1,684)
Contributions from noncontrolling interests
1,228 
80 
Distributions to noncontrolling interests
(8,152)
(6,086)
Proceeds from stock option exercises
13,796 
26,124 
Other
(28,397)
(19,526)
Net cash provided by financing activities
1,507,587 
7,830 
Net decrease in cash, cash equivalents and restricted cash
(560,562)
(283,852)
Effect of foreign currency translation
(1,758)
3,376 
Cash, cash equivalents and restricted cash at beginning of period
786,137 
957,233 
Cash, cash equivalents and restricted cash at end of period
$
223,817 
$
676,757 
See accompanying notes.
6

VENTAS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(In thousands, unaudited)
 
For the Six Months Ended June 30,
 
2026
2025
Supplemental disclosure of cash flow information:
Income taxes paid, net
$
5,576 
$
7,002 
Supplemental schedule of non-cash activities:
 
 
Assets acquired and liabilities assumed from acquisitions and other:
 
 
Real estate investments
$
448,390 
$
26,010 
Other assets
21,253 
3,106 
Debt
(289,118)
 
Other liabilities
(40,889)
10,643 
Deferred income tax liability
(55,853)
18,473 
Noncontrolling interests
(83,784)
 
See accompanying notes.
7

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






NOTE 1—DESCRIPTION OF BUSINESS

Ventas, Inc., (together with its consolidated subsidiaries, unless otherwise indicated or except where the context otherwise requires, “we,” “us,” “our,” “Ventas,” “Company” and other similar terms) is an S&P 500 company focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. We hold a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. As of June 30, 2026, we owned or had investments in 1,456 properties consisting of 1,420 properties in our reportable segments (“Segment Properties”) and 36 properties held by unconsolidated real estate entities in our non-segment operations. We are headquartered in Chicago, Illinois with additional corporate offices in Louisville, Kentucky and New York, New York.

We elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with our taxable year ended December 31, 1999. Provided we qualify for taxation as a REIT, we generally are not required to pay U.S. federal corporate income taxes on our REIT taxable income that is currently distributed to our stockholders. In order to maintain our qualification as a REIT, we must satisfy a number of technical requirements, which impact how we invest in, operate and manage our assets.

In July 2026, we completed an internal corporate reorganization (the “Reorganization”) into a holding company structure commonly referred to as an umbrella partnership real estate investment trust (“UPREIT”). As part of the Reorganization, Ventas OP LLC (the “Operating Company”) became the sole direct subsidiary of Ventas, Inc. and all other subsidiaries previously held directly by Ventas, Inc. became indirect wholly-owned subsidiaries of Ventas, Inc. As a result, we now own substantially all of our assets and conduct substantially all of our business through our Operating Company. The day-to-day management of our business remains exclusively controlled by Ventas, Inc. and the completion of the Reorganization did not result in any changes to our consolidated financial condition, results of operations or how we operate our business through our reportable segments. Accordingly, the Reorganization did not impact our current and historical financial statements.

In connection with the Reorganization, Ventas Realty, Limited Partnership (“VRLP”) was recapitalized as reflected in the Second Amended and Restated Agreement of Limited Partnership of VRLP (“VRLP Limited Partnership Agreement”) attached to this Quarterly Report on Form 10-Q as Exhibit 10. Following the recapitalization, the Operating Company holds all of VRLP’s limited partnership interests and Ventas Inc. remains VRLP’s sole general partner. The foregoing description of the VRLP Limited Partnership Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the VRLP Limited Partnership Agreement, which is incorporated herein by reference.

We operate through three reportable segments: senior housing operating portfolio, which we refer to as “SHOP,” outpatient medical and research portfolio, which we refer to as “OM&R,” and triple-net leased properties, which we refer to as “NNN.” We also hold assets outside of our reportable segments, which we refer to as non-segment assets, and which consist primarily of corporate assets, including cash and cash equivalents, restricted cash, loans receivable and investments, accounts receivable and investments in unconsolidated entities. Our investments in unconsolidated entities include investments made through our third-party institutional private capital management platform, Ventas Investment Management (“VIM”). Through VIM, we partner with third-party institutional investors to invest in real estate through various joint ventures and other co-investment vehicles where we are the sponsor or general partner, including our open-ended investment vehicle, the Ventas Life Science & Healthcare Real Estate Fund (the “Ventas Fund”). Our investments in unconsolidated entities also includes investments in operating entities, such as Ardent Health, Inc. (together with its subsidiaries, “Ardent”) and Atria Senior Living, Inc. (together with its subsidiaries, “Atria”).

Our chief operating decision maker (“CODM”) evaluates performance of the combined properties in each operating segment and determines how to allocate resources to these segments based on net operating income (“NOI”) for each segment. See “Note 16 – Segment Information.”

8

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






The following table summarizes information for our portfolio for the six months ended June 30, 2026 (dollars in thousands):
Segment
NOI (1)
Percentage of Total NOI
Segment Properties
Senior housing operating portfolio (SHOP)
$
777,957 
58.2 
%
813 
Outpatient medical and research portfolio (OM&R)
302,135 
22.6 
407 
Triple-net leased properties (NNN)
241,884 
18.1 
200 
Non-segment (2)
14,310 
1.1 
n/a
$
1,336,286 
100.0 
%
1,420 
______________________________
(1)    Net Operating Income (“NOI”) is defined as total revenues, less interest and other income, property-level operating expenses and third-party capital management expenses. See “Non-GAAP Financial Measures” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure and a reconciliation to Net income attributable to common stockholders, as computed in accordance with U.S. generally accepted accounting principles (“GAAP”), to NOI.
(2)    NOI for non-segment includes management fees and promote revenues, net of expenses related to our third-party institutional private capital management platform, income from loans and investments and corporate-level expenses not directly attributable to any of our three reportable segments.
n/a—not applicable


NOTE 2—ACCOUNTING POLICIES

The accompanying Consolidated Financial Statements have been prepared in accordance with GAAP for interim financial information set forth in the Accounting Standards Codification (“ASC”), as published by the Financial Accounting Standards Board (“FASB”), and with the Securities and Exchange Commission (“SEC”) instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim periods have been included. Operating results for the three and six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. The accompanying Consolidated Financial Statements and related notes should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Annual Report”).

Accounting Estimates

The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation

The accompanying Consolidated Financial Statements include our accounts and the accounts of our wholly-owned subsidiaries and the joint venture entities over which we exercise control. All intercompany transactions and balances have been eliminated in consolidation, and our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.

Substantially all of the assets of the consolidated variable interest entities (“VIEs”) are real estate investments and substantially all of the liabilities of the consolidated VIEs are mortgage loans. Assets of the consolidated VIEs can only be used to settle obligations of such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs. In general, any mortgage loans of the consolidated VIEs
9

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






are non-recourse to the non-VIE consolidated entities. The table below summarizes the total assets and liabilities of the consolidated VIEs as reported on our Consolidated Balance Sheets (dollars in thousands):

As of June 30, 2026
As of December 31, 2025
Total Assets
Total Liabilities
Total Assets
Total Liabilities
Fonds Immobilier Groupe Maurice, S.E.C.
$
1,749,380 
$
1,102,196 
$
1,822,300 
$
1,151,437 
NHP/PMB L.P.
644,051 
233,617 
656,813 
235,245 
Other identified VIEs
1,997,534 
545,033 
1,469,659 
467,665 

Recent Accounting Standards

On November 4, 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“DISE”), which requires disaggregated disclosure of income statement expenses for public business entities (“PBEs”). ASU 2024-03 requires PBEs to include footnote disclosure that disaggregates, in a tabular presentation, each relevant expense caption on the face of the income statement that includes certain natural expenses relevant to the Company, such as (i) employee compensation, (ii) depreciation and (iii) intangible asset amortization. The tabular disclosure must also include certain other expenses, when applicable. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. We are evaluating the impact of adopting ASU 2024-03 on our Consolidated Financial Statements.

NOTE 3—CONCENTRATION OF CREDIT RISK

We use total revenues and total NOI in assessing our concentration of credit risk. See “Non-GAAP Financial Measures” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure and a reconciliation of Net income attributable to common stockholders, as computed in accordance with GAAP, to total NOI.

We are exposed to the credit risk of our tenants in our NNN and OM&R segments because those tenants are obligated to pay us rent and, in certain instances, pay or reimburse us for some or all property-related expenses, including utilities, real estate taxes, insurance, repairs and maintenance, cleaning, roads and grounds expense and other expenses. We also have credit risk exposure with certain tenants to whom we have extended loans. Because we engage independent managers to manage the properties in our SHOP segment in exchange for a management fee, we are not directly exposed to their credit risk in the same manner or to the same extent as the tenants in our NNN and OM&R segments.

10

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






The following table summarizes certain information about our credit risk concentration related to certain NNN and OM&R tenants, including any loans made to those tenants:

 
For the Three Months Ended June 30,
For the Six Months Ended June 30,
 
2026
2025
2026
2025
Contribution as a Percentage of Total Revenues:
 
 
Ardent
2.3 
%
2.7 
%
2.3%
2.8%
Kindred Healthcare, LLC (“Kindred”)
2.0 
2.5 
2.0
2.6
Contribution as a Percentage of Total NOI:
Ardent
5.7 
%
6.5 
%
5.9%
6.6%
Kindred
5.1 
5.9 
5.2
6.1

All of the rent and loans due to us from Kindred and substantially all of the rent due to us from Ardent is guaranteed by their respective corporate parents.

Lease Income

Rental income from our NNN and OM&R operating leases consists of fixed and variable lease payments. The variable payments primarily represent (i) amounts that certain tenants pay to reimburse us for property-level operating expenses that we pay on their behalf and (ii) percentage rent, which is a rental charge typically based on certain tenants' gross revenue. Substantially all of the resident fees and services earned from our SHOP segment represent fixed income from operating leases and have not been included in the table below.

In June 2026, we amended the existing leases for all long-term acute care hospital properties leased to Kindred to, among other things, extend the term for all properties to April 30, 2039 at the existing cash base rent and substantially the same cash base rent annual escalation of 2.75% and include all Kindred-operated properties into one amended master lease (the “Kindred Master Lease”).

The following table summarizes rental income from our NNN and OM&R operating leases (dollars in thousands):

For the Three Months Ended June 30,
For the Six Months Ended June 30,
2026
2025
2026
2025
Fixed income from operating leases
$
287,313 
$
309,828 
$
572,241 
$
625,937 
Variable income from operating leases
66,148 
63,688 
134,395 
125,011 

NOTE 4—ACQUISITIONS OF REAL ESTATE PROPERTY

We acquire and invest in senior housing, outpatient medical buildings, research centers and other healthcare properties primarily to achieve an expected yield on our investment, to grow and diversify our portfolio and revenue base and to reduce our dependence on any single manager or tenant, geographic location, asset type, business model or revenue source. Each of our acquisitions disclosed below was accounted for as an asset acquisition.

2026 Acquisitions

In our SHOP segment, during the six months ended June 30, 2026, we acquired 61 senior housing communities for an aggregate purchase price of $2.8 billion.

In our SHOP segment, in July 2026, we acquired 2 senior housing communities, for an aggregate purchase price of $142.2 million.
11

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






NOTE 5—DISPOSITIONS, ASSETS HELD FOR SALE AND IMPAIRMENTS

Dispositions

During the six months ended June 30, 2026, we sold three senior housing communities in our SHOP segment, two properties in our OM&R segment and 10 properties in our NNN segment for aggregate consideration of $52.6 million and recognized $15.2 million in Gain on real estate dispositions in our Consolidated Statements of Income.

In June 2025, an existing tenant exercised a legally binding and non-cancellable option to purchase 12 OM&R properties. This transaction is accounted for as a lease modification resulting in a sales-type lease receivable of $38.5 million and a $20.8 million gain on real estate disposition. The transaction closed and the lease receivable was settled in December 2025.

Assets Held for Sale

The table below summarizes our real estate assets and liabilities classified as held for sale reported on our Consolidated Balance Sheets (dollars in thousands):

As of June 30, 2026
As of December 31, 2025
Segment Properties Held for Sale
Assets Held for Sale
Liabilities Related to Assets Held for Sale
Segment Properties Held for Sale
Assets Held for Sale
Liabilities Related to Assets Held for Sale
SHOP
7 
$
22,802 
$
2,127 
6 
$
20,337 
$
2,786 
OM&R (1)
1 
2,211 
365 
 
468 
130 
NNN
1 
3,731 
92 
10 
22,188 
1,116 
Total
9 
$
28,744 
$
2,584 
16 
$
42,993 
$
4,032 
______________________________
(1) Balances include unsettled working capital related to properties sold.
Real Estate Impairments

For the three months ended June 30, 2026, we recognized impairments of $32.0 million comprising $28.3 million, $3.3 million and $0.4 million in our SHOP, OM&R and NNN segments, respectively. For the six months ended June 30, 2026, we recognized impairments of $60.3 million comprising $30.7 million, $25.5 million and $4.1 million in our SHOP, OM&R and NNN segments, respectively. For the three months ended June 30, 2025, we recognized impairments of $34.9 million comprising $18.4 million and $16.5 million in our SHOP and OM&R segments, respectively. For the six months ended June 30, 2025, we recognized impairments of $57.2 million comprising $26.0 million, $31.1 million and $0.1 million in our SHOP, OM&R and NNN segments, respectively. The impairments were recorded primarily as a component of Depreciation and amortization in our Consolidated Statements of Income. The impairments were primarily a result of a change in our intent to hold or a change in the expected future cash flows of the impaired assets.

NOTE 6—LOANS RECEIVABLE AND INVESTMENTS, NET

As of June 30, 2026, and December 31, 2025, we held $457.1 million and $164.7 million, respectively, of loans receivable and investments, net of allowance, which are comprised of secured loans receivable and investments, net and non-mortgage loans receivable, net and relate to senior housing and healthcare operators or properties. Secured loans receivable and investments, net generally consist of sales-type lease receivables and loans that are primarily collateralized by a mortgage, a leasehold mortgage or an assignment or pledge of equity interest in entities that primarily own real estate. Non-mortgage loans receivable, net are generally corporate loans that are collateralized primarily by non-real estate related collateral or are unsecured.

12

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






In connection with a refinancing of Kindred and certain of its affiliates and parent companies (collectively, “Scion”) intended to streamline its capital structure and reduce its debt balance, in June 2026 we originated a six-year, interest-only senior secured loan to Scion with an initial principal amount of $300.0 million and an effective interest rate of 10.7% per annum (the “Scion Term Loan”).

The following is a summary of our loans receivable and investments, net (dollars in thousands):
    
Amortized Cost
Allowance
Carrying Amount
Fair Value
As of June 30, 2026:
Net real estate investments
Secured loans receivable and investments, net
$
436,401 
$
 
$
436,401 
$
442,645 
Other assets
Non-mortgage loans receivable, net
23,966 
(3,235)
20,730 
19,757 
Total loans receivable and investments, net (1)
$
460,367 
$
(3,235)
$
457,131 
$
462,402 
As of December 31, 2025:
Net real estate investments
Secured loans receivable and investments, net
$
143,913 
$
 
$
143,913 
$
146,364 
Other assets
Non-mortgage loans receivable, net
24,062 
(3,235)
20,827 
20,432 
Total loans receivable and investments, net (1)
$
167,975 
$
(3,235)
$
164,740 
$
166,796 
______________________________
(1)Loans receivable and investments, net have contractual maturities ranging from 2026 to 2041.

NOTE 7—INVESTMENTS IN UNCONSOLIDATED ENTITIES

We report investments in unconsolidated entities over whose operating and financial policies we have the ability to exercise significant influence under the equity method of accounting. Our investments in unconsolidated entities include investments in both real estate entities and operating entities as described further below. We periodically evaluate our investments in unconsolidated entities for indicators of an other-than-temporary impairment. No impairments were recognized for our investments in unconsolidated entities during the six months ended June 30, 2026 and 2025.

13

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






Investments in Unconsolidated Real Estate Entities

Below is a summary of our investments in unconsolidated real estate entities, including through VIM, as of June 30, 2026 and December 31, 2025, respectively (dollars in thousands):

Ownership (1) as of
Carrying Amount as of
June 30, 2026
December 31, 2025
June 30, 2026
December 31, 2025
Investments in unconsolidated real estate entities:
Ventas Fund
20.2%
20.1%
$
298,905 
$
288,469 
Pension Fund Joint Venture
25.0%
25.0%
5,393 
6,200 
Research & Innovation Development Joint Ventures
53.0%
53.0%
247,862 
282,512 
Ventas Investment Management platform
552,160 
577,181 
Atrium Health & Wake Forest Joint Venture
51.0%
51.0%
37,900 
39,809 
All other (2)
34.0%-37.5%
34.0%-37.5%
570 
581 
Total Investments in unconsolidated real estate entities
$
590,630 
$
617,571 
______________________________
(1)    The entities in which we have an ownership interest may have less than a 100% interest in the underlying real estate. The ownership percentages in the table reflect our interest in the entities. Joint venture members, including us in some instances, have equity participation rights based on the underlying performance of the investments, which could result in non-pro rata distributions.
(2)     Includes investments in parking structures and other de minimis investments in unconsolidated real estate entities.

During the six months ended June 30, 2026, the Ventas Fund, an equity method investee, acquired two senior housing communities for an aggregate purchase price of $109.3 million.

During the six months ended June 30, 2026, the Pension Fund Joint Venture, an equity method investee, sold one senior housing community for proceeds of $37.8 million.

In July 2026, the Ventas Fund, an equity method investee, acquired one senior housing community for a purchase price of $63.3 million.

We provide various services to our unconsolidated real estate entities in exchange for fees and reimbursements. Total management fees earned in connection with these services were $3.8 million and $3.9 million for the three months ended June 30, 2026 and 2025 and $7.6 million and $7.8 million for the six months ended June 30, 2026 and 2025, respectively. Such amounts, along with any promote revenue, are included in Third-party capital management revenues in our Consolidated Statements of Income.

Investments in Unconsolidated Operating Entities

We own investments in unconsolidated operating entities such as Atria and Ardent, which are included within Other assets on our Consolidated Balance Sheets.

As of June 30, 2026, we held a 34% ownership interest in Atria, which entitles us to customary minority rights and protections, including the right to appoint two members to the Atria Board of Directors.

As of June 30, 2026, we held an approximately 6.6% ownership interest in Ardent. One of our former executive officers is currently a member of the Ardent Board of Directors. We have the right (but not the obligation) to nominate one member of the Ardent Board of Directors for so long as we beneficially own 4% or more of the total voting power of the outstanding common stock of Ardent, pursuant to our nomination agreement with Ardent.

14

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






NOTE 8—INTANGIBLES

The following is a summary of our intangibles (dollars in thousands):

 
As of June 30, 2026
As of December 31, 2025
 
Balance
Weighted Average Remaining Amortization Period in Years
Balance
Weighted Average Remaining Amortization Period in Years
Intangible assets:
 
 
 
 
Above-market lease intangibles (1)
$
118,459 
3.9
$
120,178 
4.0
In-place lease and other real estate intangibles (2)
1,819,063 
5.3
1,560,389 
7.0
Acquired lease intangibles
1,937,522 
1,680,567 
Goodwill
1,045,816 
n/a
1,046,072 
n/a
Other intangibles (2)
41,209 
56.5
41,261 
48.0
Accumulated amortization
(1,475,052)
n/a
(1,374,077)
n/a
Net intangible assets
$
1,549,495 
6.2
$
1,393,823 
8.1
Intangible liabilities:
 
 
 
Below-market lease intangibles (1)
$
246,036 
13.4
$
246,153 
13.1
Other lease intangibles
13,498 
n/a
13,498 
n/a
Accumulated amortization
(202,832)
n/a
(198,762)
n/a
Purchase option intangibles
3,568 
n/a
3,568 
n/a
Net intangible liabilities
$
60,270 
13.4
$
64,457 
13.1
______________________________
(1)     Amortization of above- and below-market lease intangibles is recorded as a decrease and an increase to revenues, respectively, in our Consolidated Statements of Income.
(2)     Amortization of intangibles is recorded in Depreciation and amortization in our Consolidated Statements of Income.
n/a—not applicable

During the six months ended June 30, 2026, we acquired $275.2 million of intangible assets as part of our real estate acquisitions, consisting primarily of in-place lease intangibles, with a weighted average amortization period of 2.4 years at acquisition date. During the year ended December 31, 2025, we acquired $209.5 million of intangible assets as part of our real estate acquisitions, consisting primarily of in-place lease intangibles, with a weighted average amortization period of 3.5 years at acquisition date.

Other intangibles (including non-compete agreements, trade names and trademarks) are included in Other assets on our Consolidated Balance Sheets. Net intangible liabilities are included in Accounts payable and other liabilities on our Consolidated Balance Sheets.

15

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






NOTE 9—OTHER ASSETS

The following is a summary of our Other assets (dollars in thousands):

As of June 30, 2026
As of December 31, 2025
Straight-line rent receivables
$
257,139 
$
250,833 
Deferred lease costs, net
174,590 
163,481 
Accounts receivable, net (1)
108,045 
99,872 
Investment in unconsolidated operating entities
101,785 
100,614 
Prepaid assets
65,881 
81,389 
Non-mortgage loans receivable, net
20,730 
20,827 
Other intangibles, net
10,216 
10,681 
Other (2)
96,043 
97,832 
Total Other assets
$
834,429 
$
825,529 
_____________________________
(1)    Allowance for doubtful accounts as of June 30, 2026 and December 31, 2025 were $78.0 million and $71.5 million, respectively.
(2)    The balance as of December 31, 2025 included, among other items, stock warrants exercisable for 9.9% of the common equity of a parent company of Kindred at the pre-grant date value of such common equity (the “Scion Warrants”). In June 2026, we entered into an amendment to the Scion Warrants to, among other things, reduce the exercise price of the warrants and extend the warrant term to June 2036. The change in the Scion Warrants value represents partial consideration received in connection with the Kindred Master Lease amendment and the Scion Term Loan. The Scion Warrants were initially measured at fair value with changes in fair value being recognized within Other expense in our Consolidated Statements of Income.

16

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






NOTE 10—SENIOR NOTES PAYABLE AND OTHER DEBT

The following is a summary of our Senior notes payable and other debt (dollars in thousands):
As of June 30, 2026
As of December 31, 2025
Unsecured revolving credit facility (1)
$
 
$
 
Commercial paper notes
265,000 
 
4.125% Senior Notes due 2026
 
500,000 
3.75% Exchangeable Senior Notes due 2026
 
862,500 
3.25% Senior Notes due 2026
450,000 
450,000 
Unsecured term loan due February 2027
 
200,000 
2.45% Senior Notes, Series G due 2027 (2)
334,625 
346,109 
3.85% Senior Notes due 2027
400,000 
400,000 
4.00% Senior Notes due 2028
650,000 
650,000 
5.398% Senior Notes, Series I due 2028 (2)
422,684 
437,190 
4.40% Senior Notes due 2029
750,000 
750,000 
5.10% Senior Notes, Series J due 2029 (2)
457,908 
473,623 
3.00% Senior Notes due 2030
650,000 
650,000 
4.75% Senior Notes due 2030
500,000 
500,000 
2.50% Senior Notes due 2031
500,000 
500,000 
3.30% Senior Notes, Series H due 2031 (2)
211,342 
218,595 
Unsecured term loan due January 2031
1,250,000 
500,000 
5.10% Senior Notes due 2032
500,000 
500,000 
5.625% Senior Notes due 2034
500,000 
500,000 
5.00% Senior Notes due 2035
550,000 
550,000 
5.00% Senior Notes due 2036
500,000 
500,000 
6.90% Senior Notes due 2037 (3)
52,400 
52,400 
6.59% Senior Notes due 2038 (3)
21,413 
21,413 
5.70% Senior Notes due 2043
300,000 
300,000 
4.375% Senior Notes due 2045
300,000 
300,000 
4.875% Senior Notes due 2049
300,000 
300,000 
Mortgage loans and other
2,902,738 
2,641,797 
Total
12,768,110 
13,103,627 
Deferred financing costs, net
(78,069)
(81,529)
Unamortized fair value adjustment
13,487 
6,422 
Unamortized discounts
(15,739)
(17,504)
Senior notes payable and other debt
$
12,687,789 
$
13,011,016 
______________________________
(1)As of June 30, 2026 and December 31, 2025, we had no Canadian Dollar or British Pound borrowings outstanding.
(2) British Pound and Canadian Dollar debt obligations shown in US Dollars.
(3) Our 6.90% Senior Notes due 2037 are subject to repurchase at the option of the holders, at par, on October 1, 2027, and our 6.59% Senior Notes due 2038 are subject to repurchase at the option of the holders, at par, on July 7, 2028.


17

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






Credit Facilities, Commercial Paper, Unsecured Term Loans and Letters of Credit

As of June 30, 2026, we had a $3.5 billion unsecured revolving credit facility priced at the Secured Overnight Financing Rate published by the Federal Reserve Bank of New York (“SOFR”) plus 0.775% which is subject to adjustment based on the Company’s debt ratings. Our unsecured revolving credit facility matures in April 2028, and may be extended at our option, subject to the satisfaction of certain conditions, for two additional six-month periods. The unsecured revolving credit facility includes an accordion feature that permits us to increase our aggregate borrowing capacity thereunder to up to $4.5 billion, subject to the satisfaction of certain conditions, including the receipt of additional commitments for such increase.

Our unsecured revolving credit facility imposes certain customary restrictions on us, including restrictions pertaining to: (i) liens; (ii) investments; (iii) the incurrence of additional indebtedness; (iv) mergers and dissolutions; (v) certain dividend, distribution and other payments; (vi) permitted businesses; (vii) transactions with affiliates; and (viii) the maintenance of certain consolidated total leverage, secured debt leverage, unsecured debt leverage and fixed charge coverage ratios and minimum consolidated adjusted net worth, and contains certain other customary terms and conditions.

As of June 30, 2026, our $3.5 billion unsecured revolving credit facility had no borrowings outstanding and $0.8 million restricted to support outstanding letters of credit. We use our unsecured revolving credit facility to support our commercial paper program and for general corporate purposes.

Our wholly-owned subsidiary, VRLP, may issue from time to time unsecured commercial paper notes up to a maximum aggregate amount outstanding at any time of $2.5 billion, which was increased from $2.0 billion in May 2026. The notes are sold under customary terms in the U.S. commercial paper note market and are ranked pari passu with VRLP’s other unsecured senior indebtedness. The notes are fully and unconditionally guaranteed by Ventas. As of June 30, 2026 and December 31, 2025, we had $265.0 million and no borrowings, respectively, outstanding under our commercial paper program.

As of June 30, 2026, VRLP had an unsecured term loan in aggregate principal of $1.25 billion. The term loan is priced at SOFR plus 0.85%, which is subject to adjustment based on VRLP’s debt ratings. This term loan is fully and unconditionally guaranteed by Ventas and subject to certain customary covenants and other terms and conditions. It is scheduled to mature in January 2031 and includes an accordion feature that permits VRLP to increase the aggregate borrowings thereunder to up to $1.75 billion, subject to the satisfaction of certain conditions, including the receipt of additional commitments for such increase.

As of June 30, 2026, we had a $100.0 million uncommitted line for standby letters of credit, which had an outstanding balance of $28.2 million. The agreement governing the line contains certain customary covenants and other terms and conditions. Under its terms, we are required to pay a fixed rate commission on each outstanding letter of credit.

Exchangeable Senior Notes

In June 2023, VRLP issued $862.5 million aggregate principal amount of its 3.75% Exchangeable Senior Notes due 2026 (the “Exchangeable Notes”) in a private placement. The Exchangeable Notes were senior, unsecured obligations of VRLP and fully and unconditionally guaranteed on an unsecured and unsubordinated basis by Ventas. The Exchangeable Notes bore interest at a rate of 3.75% per year, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2023. The Exchangeable Notes matured in June 2026, and in accordance with the terms of the governing indenture, we settled the outstanding aggregate principal amount of the Exchange Notes with $856.1 million in cash and the conversion premium by issuing 5.9 million of Ventas common stock.

During the three and six months ended June 30, 2026, we recognized $5.2 million and $13.2 million, respectively, of contractual interest expense and amortization of issuance costs of $1.2 million and $3.1 million, respectively, related to the Exchangeable Notes.
18

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






Senior Notes

In January 2026, we repaid $500.0 million aggregate principal amount of 4.125% Senior Notes due 2026.

Mortgages

During the six months ended June 30, 2026, we used the proceeds from a new mortgage loan with a principal amount of C$92.0 million ($67.4 million) maturing in February 2031 to refinance an existing mortgage loan with a principal amount of C$87.1 million ($63.8 million).

During the three months ended June 30, 2026, in connection with certain of our senior housing acquisitions, we incurred $333.7 million of mortgage loans with maturities ranging from August 2029 to May 2031.

Scheduled Maturities of Borrowing Arrangements and Other Provisions

As of June 30, 2026, our indebtedness had the following maturities (dollars in thousands):

Principal Amount Due at Maturity
Unsecured Revolving Credit Facility and Commercial Paper Notes (1)
Scheduled Periodic Amortization
Total Maturities
Remainder of 2026
$
707,273 
$
 
$
23,809 
$
731,082 
2027
871,198 
 
46,643 
917,841 
2028
1,233,693 
265,000 
39,612 
1,538,305 
2029
2,172,985 
 
33,387 
2,206,372 
2030
1,378,029 
 
22,679 
1,400,708 
Thereafter
5,893,179 
 
80,623 
5,973,802 
Total maturities
$
12,256,357 
$
265,000 
$
246,753 
$
12,768,110 
______________________________
(1) Commercial paper notes are backstopped by the availability under the Revolving Credit Facility. As such, the Company uses the maturity date of the Revolving Credit Facility to determine the remaining term of the commercial paper notes.

The instruments governing our outstanding indebtedness contain covenants that limit our ability and the ability of certain of our subsidiaries to, among other things: (i) incur debt and certain liens; (ii) make certain dividends, distributions and investments; (iii) enter into certain transactions; and/or (iv) merge, consolidate or sell certain assets. Our credit facilities do, and certain of our other indebtedness may, require us to maintain certain financial covenants pertaining to, among other things, our consolidated total leverage, secured debt, unsecured debt, fixed charge coverage and net worth.

Derivatives and Hedging

In the normal course of our business, interest rate fluctuations affect future cash flows under our variable rate debt obligations, loans receivable and marketable debt securities, and foreign currency exchange rate fluctuations affect our operating results. We follow established risk management policies and procedures, including the use of derivative instruments, to mitigate the impact of these risks.

We do not use derivative instruments for trading or speculative purposes, and we have a policy of entering into contracts only with major financial institutions based upon their credit ratings and other factors. When considered together with the underlying exposure that the derivative is designed to hedge, we do not expect that the use of derivatives in this manner would have any material adverse effect on our future financial condition or results of operations.
19

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)







We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and variable-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements are used to hedge the variable cash flows associated with variable-rate debt.

Periodically, we enter into interest rate derivatives, such as treasury locks, to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized over the life of the related debt and recorded in Interest expense in our Consolidated Statements of Income.

As of June 30, 2026, our variable rate debt obligations of $1.9 billion reflect, in part, the effect of $74.4 million notional amount of interest rate swaps with maturities in March 2027, that effectively convert fixed rate debt to variable rate debt. These interest rate swaps were not designated for hedge accounting.

As of June 30, 2026, our fixed rate debt obligations of $10.8 billion reflect, in part, the effect of $125.1 million and C$587.6 million ($414.0 million) notional amount of interest rate swaps with maturities ranging from June 2027 to April 2031, that effectively convert variable rate debt to fixed rate debt. These interest rate swaps were designated as cash flow hedges.

2026 Activity

During the three and six months ended June 30, 2026, approximately $0.2 million and $0.7 million, respectively, of realized losses primarily relating to our interest rate swaps and treasury locks were reclassified into Interest expense in our Consolidated Statements of Income. Approximately $0.3 million of unrealized gains, which are included in Accumulated other comprehensive income as of June 30, 2026, are expected to be reclassified into earnings within the next 12 months.

NOTE 11—FAIR VALUES OF FINANCIAL INSTRUMENTS

Overview

Accounting guidance on fair value measurements for certain financial assets and liabilities requires that financial assets and liabilities carried at fair value be classified and disclosed in one of the following categories:

Level 1: Fair value calculated based on unadjusted quoted prices for identical assets or liabilities in active markets that we have the ability to access.
Level 2: Fair value calculated using inputs other than quoted prices included in level one that are directly or indirectly observable for the asset or liability. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets and other inputs for the asset or liability that are observable at commonly quoted intervals, such as interest rates, foreign exchange rates and yield curves.
Level 3: Fair value calculated using unobservable inputs for the asset or liability, which typically are based on our own assumptions, because there is little, if any, related market activity.

The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts. Accordingly, the estimates presented are not necessarily indicative of the amounts we would realize in a current market exchange or transaction.

20

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






Financial Instruments Measured at Fair Value

The table below summarizes the carrying amounts and fair values of our financial instruments either recorded or disclosed on a recurring basis (dollars in thousands):

 
As of June 30, 2026
As of December 31, 2025
 
Carrying Amount
Fair Value
Carrying Amount
Fair Value
Assets:
 
 
 
 
Cash and cash equivalents (1)
$
198,956 
$
198,956 
$
741,067 
$
741,067 
Escrow deposits and restricted cash (1)
24,861 
24,861 
45,070 
45,070 
Secured loans receivable and investments, net (3)(4)
436,401 
442,645 
143,913 
146,364 
Non-mortgage loans receivable, net (3)(4)(5)
20,730 
19,757 
20,827 
20,432 
Derivative instruments (3)(4)(5)
22,539 
22,539 
12,390 
12,390 
Liabilities:
Senior notes payable and other debt, gross (3)(4)
$
12,768,110 
$
12,605,231 
$
13,103,627 
$
13,429,007 
Derivative instruments (3)(6)
3,636 
3,636 
5,267 
5,267 
Temporary Equity:
Redeemable OP Units (2)
$
294,280 
$
294,280 
$
260,672 
$
260,672 
______________________________
(1)The carrying amount approximates fair value due to the short maturity of these instruments.
(2)Level 1 within fair value hierarchy.
(3)Level 2 within fair value hierarchy.
(4)Level 3 within fair value hierarchy.
(5)Included in Other assets on our Consolidated Balance Sheets.
(6)Included in Accounts payable and other liabilities on our Consolidated Balance Sheets.

The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts. Accordingly, the estimates presented above are not necessarily indicative of the amounts we would realize in a current market exchange.

Items Measured at Fair Value on a Recurring Basis

Our derivative instrument assets as of June 30, 2026 consist primarily of interest rate swaps and the Scion Warrants. The fair value of our interest rate swaps is based on Level 2 inputs. The Scion Warrants represent a financial interest in a private entity whose fair value is based on Level 3 inputs that reflect significant assumptions including underlying enterprise value, market volatility, duration, dividend rate and risk-free rate. Changes in one or more of these inputs could significantly impact the fair value determination.

Substantially all of our derivative instrument liabilities as of June 30, 2026 consist of interest rate swaps. Their fair value is based on Level 2 inputs.

Other Items Measured at Fair Value on a Nonrecurring Basis

Other items measured at fair value on a nonrecurring basis include assets and liabilities held for sale and real estate assets that are evaluated periodically for impairment (see “Note 5 – Dispositions, Assets Held for Sale and Impairments”). We estimate the fair value of assets held for sale and any associated impairment charges based primarily on current sales price expectations, which reside within Level 2 of the fair value hierarchy.

Real estate impairment charges recorded due to our evaluation of recoverability when events or changes in circumstances indicate the carrying amount may not be recoverable are based on company-specific inputs and our assumptions about the marketability of the properties as observable inputs are not available. As
21

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






such, we have determined that these fair value measurements generally reside within Level 3 of the fair value hierarchy. We estimate the fair value of real estate deemed to not be recoverable using the cost or income approach and unobservable data such as net operating income and estimated capitalization and discount rates, and giving consideration to local and national industry market data including comparable sales.

NOTE 12—COMMITMENTS AND CONTINGENCIES

From time to time, we are party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. In certain circumstances, regardless of whether we are a named party in a lawsuit, investigation, claim or other legal or regulatory proceeding, we may be contractually obligated to indemnify, defend and hold harmless our managers, tenants and borrowers or other third parties against, or may otherwise be responsible for, such actions, proceedings or claims. These claims may include, among other things, professional liability and general liability claims, commercial liability claims, unfair business practices claims and employment claims, as well as regulatory proceedings and government investigations, including proceedings related to our senior housing operating portfolio, where we are typically the holder of the applicable healthcare license. These claims may not be fully insured and some may allege large damage amounts.

It is the opinion of management, that the disposition of any such lawsuits, investigations, claims and other legal and regulatory proceedings that are currently pending will not, individually or in the aggregate, have a material adverse effect on us. However, regardless of the merits of a particular action, investigation or claim, we may be forced to expend significant financial resources to defend and resolve these matters. We are unable to predict the ultimate outcome of these lawsuits, investigations, claims and other legal and regulatory proceedings, and, if management’s assessment of our liability with respect thereto is incorrect, such actions, investigations and claims could have a material adverse effect on us.

From time to time, on behalf of ourselves or on behalf of our unconsolidated entities, we have agreed, and may in the future agree, to provide guarantees, indemnities or other similar contingent obligations to third parties. Such agreements may include, without limitation: (i) guarantees of all or a portion of the principal, interest and other amounts due under mortgage debt or other borrowings; (ii) customary nonrecourse carve-out guarantees provided in connection with mortgage or other borrowings; (iii) customary indemnifications of lenders for potential environmental liabilities; (iv) completion guarantees provided to lenders, tenants, ground lessors or other third parties for the completion of development and redevelopment projects; (v) guarantees of payment of contingent tax obligations to tax credit investors who have purchased historic, new market and other tax credits from us or our unconsolidated entities; (vi) guarantees of ground rent and other payment of ground rent and other obligations to ground lessors; and (vii) indemnities and other guarantees required in connection with the procurement of performance and surety bonds and standby letters of credit.

As of June 30, 2026, no triggering events relating to our guarantees, indemnities or similar contingent obligations have occurred. Accordingly, no contingent liability is recorded in our Consolidated Balance Sheets.

NOTE 13—INCOME TAXES

We have elected to be taxed as a REIT under the applicable provisions of the Internal Revenue Code of 1986, as amended, for every year beginning with the year ended December 31, 1999. We have also elected for certain of our subsidiaries to be treated as taxable REIT subsidiaries (“TRS” or “TRS entities”), which are subject to federal, state and foreign income taxes. All entities other than the TRS entities are collectively referred to as the “REIT” within this note. Certain REIT entities are subject to foreign income tax.

Although the TRS entities and certain other foreign entities have paid minimal federal, state and foreign income taxes for the six months ended June 30, 2026, their income tax liabilities may increase in future periods as we exhaust net operating loss (“NOL”) carryforwards and as our operations grow. Such increases could be significant.

22

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






Our consolidated provision for income taxes for the three months ended June 30, 2026 and 2025 was a benefit of $25.6 million and an expense of $3.9 million, respectively. Our consolidated provision for income taxes for the six months ended June 30, 2026 and 2025 was a benefit of $41.6 million and a benefit of $6.7 million, respectively. The income tax benefit for the three months ended June 30, 2026 is primarily due to the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities, partially offset by increases in the valuation allowance for certain TRS entities during the period. The $3.9 million income tax expense for the three months ended June 30, 2025 was primarily due to certain of our TRS entities incurring tax expense as a result of interest expense in excess of certain deduction thresholds, partially offset by the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities. The income tax benefit for the six months ended June 30, 2026 was primarily due to the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities, partially offset by increases in the valuation allowance for certain TRS entities during the periods. The income tax benefit for the six months ended June 30, 2025 was primarily due to the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities.

Each TRS is a tax paying component for purposes of classifying deferred tax assets and liabilities. Deferred tax liabilities with respect to our TRS entities totaled $30.7 million and $23.4 million as of June 30, 2026 and December 31, 2025, respectively, and related primarily to differences between the financial reporting and tax bases of fixed and intangible assets, net of loss carryforwards. Deferred tax assets with respect to our TRS entities totaled $3.1 million and $2.8 million as of June 30, 2026 and December 31, 2025, respectively, and related primarily to loss carryforwards.
    
Generally, we are subject to audit under the statute of limitations by the Internal Revenue Service for the year ended December 31, 2022 and subsequent years and are subject to audit by state taxing authorities for the year ended December 31, 2021 and subsequent years. We are subject to audit generally under the statutes of limitation by the Canada Revenue Agency and provincial authorities with respect to the Canadian entities for the year ended December 31, 2021 and subsequent years. We are subject to audit in the United Kingdom generally for periods ended in and subsequent to 2024.

NOTE 14—STOCKHOLDERS' EQUITY

Capital Stock

Equity Forward Sales Agreements

We have established an at-the-market offering program that provides for the sale, from time to time, of shares of our common stock, including through forward sales agreements, as described in more detail below (the "ATM Program"). In May 2026, we amended the existing ATM Program such that the aggregate gross sales price of common stock available for issuance increased from $2.5 billion to $3.0 billion. As of June 30, 2026, the remaining amount available under the ATM Program for future sales of common stock was $2.3 billion.

During the three months ended June 30, 2026, we entered into equity forward sales agreements under the ATM Program for 20.9 million shares of our common stock for gross proceeds of $1.8 billion, representing an average price of $86.94 per share. During the three months ended June 30, 2026, we settled 20.8 million shares of common stock under outstanding equity forward sales agreements entered into under the ATM Program for net cash proceeds of $1.7 billion.

During the six months ended June 30, 2026, we entered into equity forward sales agreements under the ATM Program for 34.7 million shares of our common stock for gross proceeds of $3.0 billion, representing an average price of $86.02 per share. During the six months ended June 30, 2026, we settled 31.4 million shares of common stock under outstanding equity forward sales agreements entered into under the ATM Program for net cash proceeds of $2.5 billion.

As of June 30, 2026, we maintained unsettled equity forward sales agreements for 17.2 million shares of common stock, or approximately $1.5 billion in gross proceeds, with varying maturities through December 2027.

23

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






In July 2026, we entered into equity forward sales agreements under the ATM Program for 1.3 million shares of common stock or approximately $119.7 million in gross proceeds which remain unsettled with maturity in December 2027. As of July 30, 2026, the remaining amount available under the ATM Program for future sales of common stock was $2.0 billion, and we maintained unsettled equity forward sales agreements of 18.5 million shares of common stock, or approximately $1.6 billion in gross proceeds, with varying maturities through December 2027.

From time to time, including under the ATM Program, we may enter into equity forward sales agreements. An equity forward sales agreement enables us to secure a share price on the sale of shares of our common stock at or shortly after the time the forward sales agreement becomes effective, while postponing the receipt of proceeds from the sale of shares until a future date. Equity forward sales agreements generally have a maturity of one to two years. At any time during the term of an equity forward sales agreement, we may settle that equity forward sales agreement by delivery of physical shares of our common stock to the forward purchaser or, at our election, subject to certain exceptions, we may settle in cash or by net share settlement. The forward sales price we expect to receive upon settlement of outstanding equity forward sales agreements will be the initial forward price, net of commissions, established on or shortly after the effective date of the relevant equity forward sales agreement, subject to adjustments for accrued interest, the forward purchasers’ stock borrowing costs in excess of a certain threshold specified in the equity forward sales agreement and certain fixed price reductions for expected dividends on our common stock during the term of the equity forward sales agreement. Our unsettled equity forward sales agreements are accounted for as equity instruments. Refer to “Note 15 – Earnings Per Share.”

Accumulated Other Comprehensive Loss

The following is a summary of our Accumulated other comprehensive loss (dollars in thousands):

As of June 30, 2026
As of December 31, 2025
Foreign currency translation loss
$
(27,868)
$
(33,081)
Unrealized loss on available for sale securities
(1,642)
(1,298)
Unrealized loss on derivative instruments
(2,000)
(5,472)
Total Accumulated other comprehensive loss
$
(31,510)
$
(39,851)

24

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






NOTE 15—EARNINGS PER SHARE

The following table shows the amounts used in computing our basic and diluted earnings per share (in thousands, except per share amounts):

 
For the Three Months Ended June 30,
For the Six Months Ended June 30,
 
2026
2025
2026
2025
Numerator for basic and diluted earnings per share:
 
 
Net income
$
72,222 
$
71,462 
$
131,268 
$
119,818 
Net income attributable to noncontrolling interests
1,652 
3,198 
4,786 
4,686 
Net income attributable to common stockholders
$
70,570 
$
68,264 
$
126,482 
$
115,132 
Denominator:
 
 
Denominator for basic earnings per share—weighted average shares
489,287 
452,583 
482,802 
446,314 
Effect of dilutive securities:
 
 
Restricted stock awards
533 
504 
606 
550 
OP unitholder interests
3,317 
3,380 
3,338 
3,390 
Exchangeable Notes
3,882 
2,535 
4,553 
2,378 
Equity forward sales agreements
705 
86 
983 
368 
Denominator for diluted earnings per share—adjusted weighted average shares
497,724 
459,088 
492,282 
453,000 
Basic earnings per share:
 
 
Net income
$
0.15 
$
0.16 
$
0.27 
$
0.27 
Net income attributable to common stockholders
0.14 
0.15 
0.26 
0.26 
Diluted earnings per share:
 
 
 
 
Net income
$
0.15 
$
0.16 
$
0.27 
$
0.26 
Net income attributable to common stockholders
0.14 
0.15 
0.26 
0.25 

The dilutive effect of our Exchangeable Notes is calculated using the if-converted method in accordance with ASU 2020-06. We are required, pursuant to the indenture governing the Exchangeable Notes, to settle the aggregate principal amount of the Exchangeable Notes in cash and may elect to settle any remaining exchange obligation (i.e., the stock price in excess of the exchange obligation) in cash, shares of our common stock or a combination thereof. Under the if-converted method, we include the number of shares required to satisfy the exchange obligation, assuming all the Exchangeable Notes are exchanged. All remaining Exchangeable Notes were settled in June 2026. Refer to “Note 10 – Senior Notes Payable and Other Debt”. As a result, shares issued upon settlement are included in the calculation of basic weighted shares outstanding beginning on the settlement date. For the period in which the dilutive securities were outstanding, the average closing price of our common stock is used as the basis for determining the dilutive effect on earnings per share.

Our unsettled equity forward sales agreements do not impact basic earnings per share. We apply the treasury stock method to our unsettled equity forward sales agreements to determine their dilutive effect, if any. See “Note 14 – Stockholders' Equity.”

25

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






NOTE 16—SEGMENT INFORMATION

As of June 30, 2026, we operated through three reportable segments: SHOP, OM&R and NNN. In our SHOP segment, we own and invest in senior housing communities and engage operators to operate those communities. In our OM&R segment, we primarily acquire, own, develop, lease and manage outpatient medical buildings and research centers. In our NNN segment, we invest in and own senior housing communities, skilled nursing facilities (“SNFs”), long-term acute care facilities (“LTACs”), freestanding inpatient rehabilitation facilities (“IRFs”) and other healthcare facilities and lease the properties to tenants under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures. Information provided for “non-segment” includes management fees and promote revenues, net of expenses related to our third-party institutional private capital management platform, income from loans and investments and corporate-level expenses not directly attributable to any of our three reportable segments. Non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, loans receivable and investments and accounts receivable. Total assets by reportable segment is not disclosed as the CODM does not review such information to evaluate business performance and allocate resources.

Our CODM is the Chief Executive Officer of the Company. Our CODM evaluates performance of the combined properties in each operating segment and determines how to allocate resources to these segments, based on NOI for each segment. Our CODM uses NOI to assess the performance of each segment and to allocate resources (including employees and financial or capital resources) primarily during the quarterly or annual business review and annual budget and forecasting process. We define NOI as total revenues, less interest and other income, property-level operating expenses and third-party capital management expenses.

Interest expense, depreciation and amortization, general, administrative and professional fees, income tax expense and other non-property-specific revenues and expenses are not allocated to individual reportable segments for purposes of assessing segment performance. There are no intersegment sales or transfers.

26

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






Summary information by reportable segment is as follows (dollars in thousands):

For the Three Months Ended June 30, 2026
SHOP
OM&R
NNN
Non-Segment
Total
Revenues
 
 
 
 
 
Rental income
$
 
$
228,605 
$
124,856 
$
 
$
353,461 
Resident fees and services
1,363,498 
 
 
 
1,363,498 
Third-party capital management revenues
 
708 
3,537 
4,245 
Income from loans and investments
 
 
 
6,632 
6,632 
Interest and other income
 
 
 
1,778 
1,778 
Total revenues
$
1,363,498 
$
229,313 
$
124,856 
$
11,947 
$
1,729,614 
Total revenues
$
1,363,498 
$
229,313 
$
124,856 
$
11,947 
$
1,729,614 
Less:
 
 
 
 
 
Interest and other income
 
 
 
1,778 
1,778 
Labor (1)
539,311 
 
 
 
539,311 
Management fees
72,986 
 
 
 
72,986 
Other segment expenses (2)
347,702 
77,781 
3,142 
 
428,625 
Property-level operating expenses
959,999 
77,781 
3,142 
 
1,040,922 
Third-party capital management expenses
 
 
 
1,706
1,706 
NOI
$
403,499 
$
151,532 
$
121,714 
$
8,463 
685,208 
Interest and other income
 
 
 
 
1,778 
Interest expense
 
 
 
 
(160,034)
Depreciation and amortization
 
 
 
 
(407,711)
General, administrative and professional fees
 
 
 
 
(46,986)
Loss on extinguishment of debt, net
(83)
Transaction, transition and restructuring costs
 
 
 
 
(13,478)
Other expense
 
 
 
 
(4,454)
Loss from unconsolidated entities
(7,812)
Gain on real estate dispositions
176 
Income tax benefit
 
 
 
 
25,618 
Net income
72,222 
Net income attributable to noncontrolling interests
1,652 
Net income attributable to common stockholders
$
70,570 
______________________________
(1)     Labor expense primarily includes salaries, benefits and related taxes.
(2)    Other segment expenses include:
SHOP — food, utilities, real estate taxes, insurance, repairs and maintenance, marketing, supplies and other expenses.
OM&R — utilities, real estate taxes, insurance, repairs and maintenance, cleaning, roads and grounds expense and other expenses.
NNN — real estate taxes and insurance.
The CODM does not regularly receive significant expense details for the OM&R or the NNN segments and focuses on monitoring revenues and NOI because a significant majority or all of the property-level operating expenses are recovered from the tenants.
27

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






For the Three Months Ended June 30, 2025
SHOP
OM&R
NNN
Non-Segment
Total
Revenues
 
 
 
 
 
Rental income
$
 
$
220,814 
$
152,702 
$
 
$
373,516 
Resident fees and services
1,032,714 
 
 
 
1,032,714 
Third-party capital management revenues
 
673 
 
3,724 
4,397 
Income from loans and investments
 
 
 
4,395 
4,395 
Interest and other income
 
 
 
5,871 
5,871 
Total revenues
$
1,032,714 
$
221,487 
$
152,702 
$
13,990 
$
1,420,893 
Total revenues
$
1,032,714 
$
221,487 
$
152,702 
$
13,990 
$
1,420,893 
Less:
 
 
 
 
 
Interest and other income
 
 
 
5,871 
5,871 
Labor (1)
420,212 
 
 
 
420,212 
Management fees
54,421 
 
 
 
54,421 
Other segment expenses (2)
271,669 
75,001 
3,966 
 
350,636 
Property-level operating expenses
746,302 
75,001 
3,966 
 
825,269 
Third-party capital management expenses
 
 
 
1,627 
1,627 
NOI
$
286,412 
$
146,486 
$
148,736 
$
6,492 
588,126 
Interest and other income
 
 
 
 
5,871 
Interest expense
 
 
 
 
(150,298)
Depreciation and amortization
 
 
 
 
(347,719)
General, administrative and professional fees
 
 
 
 
(42,856)
Transaction, transition and restructuring costs
 
 
 
 
(4,627)
Other expense
 
 
 
 
(5,839)
Loss from unconsolidated entities
(1,138)
Gain on real estate dispositions
33,816 
Income tax expense
 
 
 
 
(3,874)
Net income
71,462 
Net income attributable to noncontrolling interests
3,198 
Net income attributable to common stockholders
$
68,264 
______________________________
(1)     Labor expense primarily includes salaries, benefits and related taxes.
(2)    Other segment expenses include:
SHOP — food, utilities, real estate taxes, insurance, repairs and maintenance, marketing, supplies and other expenses.
OM&R — utilities, real estate taxes, insurance, repairs and maintenance, cleaning, roads and grounds expense and other expenses.
NNN — real estate taxes and insurance.
The CODM does not regularly receive significant expense details for the OM&R or the NNN segments and focuses on monitoring revenues and NOI because a significant majority or all of the property-level operating expenses are recovered from the tenants.
28

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






For the Six Months Ended June 30, 2026
SHOP
OM&R
NNN
Non-Segment
Total
Revenues
 
 
 
 
 
Rental income
$
 
$
458,709 
$
247,927 
$
 
$
706,636 
Resident fees and services
2,656,288 
 
 
 
2,656,288 
Third-party capital management revenues
 
1,508 
 
7,148 
8,656 
Income from loans and investments
 
 
 
10,701 
10,701 
Interest and other income
 
 
 
4,277 
4,277 
Total revenues
$
2,656,288 
$
460,217 
$
247,927 
$
22,126 
$
3,386,558 
Total revenues
$
2,656,288 
$
460,217 
$
247,927 
$
22,126 
$
3,386,558 
Less:
 
 
 
 
 
Interest and other income
 
 
 
4,277 
4,277 
Labor (1)
1,053,272 
 
 
 
1,053,272 
Management fees
140,549 
 
 
 
140,549 
Other segment expenses (2)
684,510 
158,082 
6,043 
 
848,635 
Property-level operating expenses
1,878,331 
158,082 
6,043 
 
2,042,456 
Third-party capital management expenses
 
 
 
3,539 
3,539 
NOI
$
777,957 
$
302,135 
$
241,884 
$
14,310 
1,336,286 
Interest and other income
 
 
 
 
4,277 
Interest expense
 
 
 
 
(316,176)
Depreciation and amortization
 
 
 
 
(790,179)
General, administrative and professional fees
 
 
 
 
(109,732)
Loss on extinguishment of debt, net
(532)
Transaction, transition and restructuring costs
 
 
 
 
(20,137)
Other expense
 
 
 
 
(14,154)
Loss from unconsolidated entities
(15,162)
Gain on real estate dispositions
15,222 
Income tax benefit
 
 
 
 
41,555 
Net income
131,268 
Net income attributable to noncontrolling interests
4,786 
Net income attributable to common stockholders
 
 
 
 
$
126,482 
______________________________
(1)     Labor expense primarily includes salaries, benefits and related taxes.
(2)    Other segment expenses include:
SHOP — food, utilities, real estate taxes, insurance, repairs and maintenance, marketing, supplies and other expenses.
OM&R — utilities, real estate taxes, insurance, repairs and maintenance, cleaning, roads and grounds expense and other expenses.
NNN — real estate taxes and insurance.
The CODM does not regularly receive significant expense details for the OM&R or the NNN segments and focuses on monitoring revenues and NOI because a significant majority or all of the property-level operating expenses are recovered from the tenants.

29

VENTAS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)






For the Six Months Ended June 30, 2025
SHOP
OM&R
NNN
Non-Segment
Total
Revenues
 
 
 
 
 
Rental income
$
 
$
442,133 
$
308,815 
$
 
$
750,948 
Resident fees and services
2,001,618 
 
 
 
2,001,618 
Third-party capital management revenues
 
1,353 
 
7,380 
8,733 
Income from loans and investments
 
 
 
8,719 
8,719 
Interest and other income
 
 
 
8,949 
8,949 
Total revenues
$
2,001,618 
$
443,486 
$
308,815 
$
25,048 
$
2,778,967 
Total revenues
$
2,001,618 
$
443,486 
$
308,815 
$
25,048 
$
2,778,967 
Less:
 
 
 
 
 
Interest and other income
 
 
 
8,949 
8,949 
Labor (1)
812,836 
 
 
 
812,836 
Management fees
105,032 
 
 
 
105,032 
Other segment expenses (2)
532,834 
150,958 
7,493 
 
691,285 
Property-level operating expenses
1,450,702 
150,958 
7,493 
 
1,609,153 
Third-party capital management expenses
 
 
 
3,452 
3,452 
NOI
$
550,916 
$
292,528 
$
301,322 
$
12,647 
1,157,413 
Interest and other income
 
 
 
 
8,949 
Interest expense
 
 
 
 
(299,654)
Depreciation and amortization
 
 
 
 
(669,244)
General, administrative and professional fees
 
 
 
 
(96,005)
Transaction, transition and restructuring costs
 
 
 
 
(10,609)
Other expense
 
 
 
 
(7,251)
Loss from unconsolidated entities
(4,449)
Gain on real estate dispositions
33,985 
Income tax benefit
 
 
 
 
6,683 
Net income
119,818 
Net income attributable to noncontrolling interests
4,686 
Net income attributable to common stockholders
$
115,132 
______________________________
(1)     Labor expense primarily includes salaries, benefits and related taxes.
(2)    Other segment expenses include:
SHOP — food, utilities, real estate taxes, insurance, repairs and maintenance, marketing, supplies and other expenses.
OM&R — utilities, real estate taxes, insurance, repairs and maintenance, cleaning, roads and grounds expense and other expenses.
NNN — real estate taxes and insurance.
The CODM does not regularly receive significant expense details for the OM&R or the NNN segments and focuses on monitoring revenues and NOI because a significant majority or all of the property-level operating expenses are recovered from the tenants.

30

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless otherwise indicated or except where the context otherwise requires, the terms “we,” “us,” “our,” “Company” and other similar terms in Item 2 of this Quarterly Report on Form 10-Q refer to Ventas, Inc. and its consolidated subsidiaries.

Cautionary Statements

Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of phrases or words such as “assume,” “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “target,” “forecast,” “plan,” “line-of-sight,” “outlook,” “potential,” “opportunity,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof.

Forward-looking statements are based on management’s beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. We urge you to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the sections titled “Cautionary Statements — Summary Risk Factors” and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, this Quarterly Report on Form 10-Q and our Current Reports on Form 8-K as we file them with the Securities and Exchange Commission.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our exposure and the exposure of our managers, tenants and borrowers to complex and evolving governmental policy, laws and regulations, including relating to healthcare, data privacy, cybersecurity, artificial intelligence, international trade and environmental matters, the impact of such policies, laws and regulations on our and our managers’, tenants’ and borrowers’ business and the challenges and expense associated with complying with such policies, laws and regulations; (b) the impact of market, macroeconomic and general economic conditions on us, our managers, tenants and borrowers and in areas in which our properties are geographically concentrated, including changes in or elevated inflation, interest rates and exchange rates, labor market dynamics and rises in unemployment, tightening of lending standards and reduced availability of credit or capital, events that affect consumer confidence, and the actual and perceived state of the real estate markets and public and private capital markets; (c) our ability, and the ability of our managers, tenants and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, including their ability to respond to the impact of the U.S. political environment on government funding and reimbursement programs, and the financial condition or business prospect of our managers, tenants and borrowers; (d) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments; (e) our ability to identify and consummate future investments in healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests; (f) the potential for significant general and commercial claims, legal actions, investigations, regulatory proceedings and enforcement actions that could subject us or our managers, tenants or borrowers to increased operating costs, uninsured liabilities, including fines and other penalties, reputational harm or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (g) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for, or lease from, us, which limits our control and influence over such properties, their operations and their performance; (h) our reliance
31

and the reliance of our managers, tenants and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained; (i) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our managers, tenants borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us; (j) our dependency on a limited number of managers and tenants for a significant portion of our revenues and operating income; (k) our exposure to various operational risks, liabilities and claims from our operating assets; (l) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the healthcare real estate sector, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (m) our ownership of properties or operation of business outside of the U.S. that may subject us to different or greater risks than those associated with our domestic operations; (n) the risk that our management agreements or leases are not renewed or are renewed on less favorable terms, that our managers or tenants default under those agreements or that we are unable to replace managers or tenants on a timely basis or on favorable terms, if at all; (o) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (p) risks related to the recognition of reserves, allowances, credit losses or impairment charges which are inherently uncertain and may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets; (q) the risk of exposure to unknown liabilities from our investments in properties or businesses; (r) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our managers, tenants or borrowers; (s) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (t) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries’ existing indebtedness; (u) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (v) the risk of potential dilution resulting from future sales or issuances of our equity securities; (w) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our managers, tenants, borrowers or other counterparties; (x) the risks or uncertainties relating to the use of, or inability to take advantage of, the benefits of artificial intelligence by us or our managers, tenants or borrowers; (y) the occurrence of cybersecurity threats and incidents that could disrupt our or our managers’, tenants’ or borrower’s operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (z) the risk of catastrophic or extreme weather and other natural events; (aa) our ability to attract and retain talented employees; (bb) our ability to maintain a positive reputation for quality and service with our key stakeholders; (cc) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (dd) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; and (ee) risks and uncertainties related to the UPREIT Reorganization; (ff) the other factors set forth in our periodic filings with the Securities and Exchange Commission.

Note Regarding Third-Party Information

This Quarterly Report includes information that has been derived from SEC filings that have been provided to us by our tenants and managers or been derived from SEC filings or other publicly available information of our tenants and managers. We believe that such information is accurate and that the sources from which it has been obtained are reliable. However, we cannot guarantee the accuracy of such information and have not independently verified the assumptions on which such information is based.

Company Overview

Ventas, Inc. is an S&P 500 company focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. We hold a portfolio that
32

includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. As of June 30, 2026, we owned or had investments in 1,456 properties consisting of 1,420 properties in our reportable segments (“Segment Properties”) and 36 properties held by unconsolidated real estate entities in our non-segment operations. We are headquartered in Chicago, Illinois with additional corporate offices in Louisville, Kentucky and New York, New York.

We elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with our taxable year ended December 31, 1999. Provided we qualify for taxation as a REIT, we generally are not required to pay U.S. federal corporate income taxes on our REIT taxable income that is currently distributed to our stockholders. In order to maintain our qualification as a REIT, we must satisfy a number of technical requirements, which impact how we invest in, operate and manage our assets.

    In July 2026, we completed an internal corporate reorganization (the “Reorganization”) into a holding company structure commonly referred to as an umbrella partnership real estate investment trust (“UPREIT”). As part of the Reorganization, Ventas OP LLC (the “Operating Company”) became the sole direct subsidiary of Ventas, Inc. and all other subsidiaries previously held directly by Ventas, Inc. became indirect wholly-owned subsidiaries of Ventas, Inc. As a result, we now own substantially all of our assets and conduct substantially all of our business through our Operating Company. The day-to-day management of our business remains exclusively controlled by Ventas, Inc. and the completion of the Reorganization did not result in any changes to our consolidated financial condition, results of operations or how we operate our business through our reportable segments. Accordingly, the Reorganization did not impact our current and historical financial statements.

In connection with the Reorganization, Ventas Realty, Limited Partnership (“VRLP”) was recapitalized as reflected in the Second Amended and Restated Agreement of Limited Partnership of VRLP (“VRLP Limited Partnership Agreement”) attached to this Quarterly Report on Form 10-Q as Exhibit 10. Following the recapitalization, the Operating Company holds all of VRLP’s limited partnership interests and Ventas Inc. remains VRLP’s sole general partner. The foregoing description of the VRLP Limited Partnership Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the VRLP Limited Partnership Agreement, which is incorporated herein by reference.

We operate through three reportable segments: senior housing operating portfolio, which we refer to as “SHOP,” outpatient medical and research portfolio, which we refer to as “OM&R,” and triple-net leased properties, which we refer to as “NNN.” We also hold assets outside of our reportable segments, which we refer to as non-segment assets, and which consist primarily of corporate assets, including cash and cash equivalents, restricted cash, loans receivable and investments, accounts receivable and investments in unconsolidated entities. Our investments in unconsolidated entities include investments made through our third-party institutional private capital management platform, Ventas Investment Management (“VIM”). Through VIM, we partner with third-party institutional investors to invest in real estate through various joint ventures and other co-investment vehicles where we are the sponsor or general partner, including our open-ended investment vehicle, the Ventas Life Science & Healthcare Real Estate Fund (the “Ventas Fund”). Our investments in unconsolidated entities also includes investments in operating entities, such as Ardent Health, Inc. (together with its subsidiaries, “Ardent”) and Atria Senior Living, Inc. (together with its subsidiaries, “Atria”).

Our chief operating decision maker (“CODM”) evaluates performance of the combined properties in each operating segment and determines how to allocate resources to these segments based on net operating income (“NOI”) for each segment. See our Consolidated Financial Statements and the related notes, including “Note 16 – Segment Information,” included in Item 1 of this Quarterly Report on Form 10-Q.

33

The following table summarizes information for our portfolio for the six months ended June 30, 2026 (dollars in thousands):
Segment
NOI (1)
Percentage of Total NOI
Segment Properties
Senior housing operating portfolio (SHOP)
$
777,957 
58.2 
%
813 
Outpatient medical and research portfolio (OM&R)
302,135 
22.6 
407 
Triple-net leased properties (NNN)
241,884 
18.1 
200 
Non-segment (2)
14,310 
1.1 
n/a
$
1,336,286 
100.0 
%
1,420 
______________________________
(1)    Net Operating Income (“NOI”) is defined as total revenues, less interest and other income, property-level operating expenses and third-party capital management expenses. See “Non-GAAP Financial Measures” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure and a reconciliation to Net income attributable to common stockholders, as computed in accordance with U.S. generally accepted accounting principles (“GAAP”), to NOI.
(2)    NOI for non-segment includes management fees and promote revenues, net of expenses related to our third-party institutional private capital management platform, income from loans and investments and corporate-level expenses not directly attributable to any of our three reportable segments.
n/a—not applicable

Business Strategy

For nearly three decades, Ventas has pursued a strategy focused on delivering outsized value to stockholders and other key stakeholders by enabling exceptional environments that benefit a large and growing aging population. Working with industry-leading care providers, partners and research and medical institutions, our collaborative and experienced team is focused on achieving consistent, superior total returns through: (1) delivering profitable organic growth in senior housing, (2) capturing value-creating external growth focused on senior housing, (3) generating strong cash flow throughout our portfolio of high-quality assets unified in meeting demographic demand and (4) maintaining financial strength, flexibility and liquidity.
Our objective is to generate reliable and growing cash flows from our portfolio, which enables us to pay regular cash dividends to stockholders and creates opportunities to increase stockholder value.

Market Trends

Our operations have historically been and are expected to continue to be impacted by economic and market conditions. We expect senior housing to benefit from strong supply/demand fundamentals, including robust projected demand growth combined with low projected supply growth.

The performance and growth of our business will also depend on the broader macroeconomic environment, including consumer sentiment, interest rates, inflation and GDP growth.

See “Risk Factors” in Part I, Item 1A of our 2025 Annual Report for additional discussion of risks affecting our business.

2026 Highlights

Investments and Dispositions

In our SHOP segment, during the six months ended June 30, 2026, we acquired 61 senior housing communities for an aggregate purchase price of $2.8 billion.

During the six months ended June 30, 2026, we sold three senior housing communities in our SHOP segment, two properties in our OM&R segment and 10 properties in our NNN segment formerly leased to Brookdale Senior Living (“Brookdale”), for aggregate consideration of $52.6 million and recognized $15.2 million in Gain on real estate dispositions in our Consolidated Statements of Income.
34


In our SHOP segment, in July 2026, we acquired 2 senior housing communities, for an aggregate purchase price of $142.2 million.

Liquidity and Capital

As of June 30, 2026, we had $4.9 billion in liquidity, including approximately $3.5 billion of availability under our unsecured revolving credit facility, $199.0 million of cash and cash equivalents on hand, and $1.5 billion of estimated proceeds available under unsettled equity forward sales agreements, calculated using the forward price, net of fees, partially offset by $265.0 million in borrowings outstanding under our commercial paper program and $28.2 million outstanding under our uncommitted line for standby letters of credit.

In January 2026, VRLP amended the existing $500 million unsecured term loan due June 2027 to, among other things, extend the maturity to January 2031 and increase the aggregate principal borrowings to up to $1.25 billion. In connection with the amendment, VRLP also repaid in full a $200 million unsecured term loan due February 2027. As of June 30, 2026, aggregate principal of $1.25 billion was outstanding.

In May 2026, we increased the amount that VRLP may issue from time to time under its commercial paper program from a maximum aggregate amount outstanding at any time of $2.0 billion to $2.5 billion. Other than the increase in the program’s maximum capacity, the other terms of the commercial paper program remained unchanged.

Senior Notes

In January 2026, we repaid $500.0 million aggregate principal amount of 4.125% Senior Notes due 2026.
In June 2026, we settled the outstanding aggregate principal amount of $856.1 million of the exchangeable notes in cash and the conversion premium by issuing 5.9 million of Ventas common stock.

Mortgages

During the six months ended June 30, 2026, we used the proceeds from a new mortgage loan with a principal amount of C$92.0 million ($67.4 million) maturing in February 2031 to refinance an existing mortgage loan with a principal amount of C$87.1 million ($63.8 million).

During the three months ended June 30, 2026, in connection with certain of our senior housing acquisitions, we incurred $333.7 million of mortgage loans with maturities ranging from August 2029 to May 2031.

Equity

In May 2026, we amended the existing ATM Program such that the aggregate gross sales price of common stock available for issuance increased from $2.5 billion to $3.0 billion.

During the three months ended June 30, 2026, we entered into equity forward sales agreements under the ATM Program for 20.9 million shares of our common stock for gross proceeds of $1.8 billion, representing an average price of $86.94 per share. During the three months ended June 30, 2026, we settled 20.8 million shares of common stock under outstanding equity forward sales agreements entered into under the ATM Program for net cash proceeds of $1.7 billion.

In July 2026, we entered into equity forward sales agreements under the ATM Program for 1.3 million shares of common stock or approximately $119.7 million in gross proceeds which remain unsettled with maturity in December 2027. As of July 30, 2026, the remaining amount available under the ATM Program for future sales of common stock was $2.0 billion, and we maintained unsettled equity forward sales agreements of 18.5 million shares of common stock, or approximately $1.6 billion in gross proceeds, with varying maturities through December 2027.

35

Other Items

During the six months ended June 30, 2026, the Ventas Fund, an equity method investee, acquired two senior housing communities for an aggregate purchase price of $109.3 million.

During the six months ended June 30, 2026, the Pension Fund Joint Venture, an equity method investee, sold one senior housing community for proceeds of $37.8 million.

In July 2026, the Ventas Fund, an equity method investee, acquired one senior housing community for a purchase price of $63.3 million.
In June 2026, we amended the existing leases for all long-term acute care hospital properties leased to Kindred to, among other things, extend the term for all properties to April 30, 2039 at the existing cash base rent and substantially the same cash base rent annual escalation of 2.75% and include all Kindred-operated properties into one amended master lease (the “Kindred Master Lease”). Additionally, in connection with a refinancing of Scion intended to streamline its capital structure and reduce its debt balance, we originated a six-year, interest-only senior secured loan to Scion, with an initial principal amount of $300.0 million and an effective interest rate of 10.7% per annum. We also entered into an amendment to our existing Scion Warrants to, among other things, reduce the exercise price and extend the warrant term to 10 years.


Critical Accounting Policies and Estimates

Our Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q have been prepared in accordance with GAAP for interim financial information set forth in the Accounting Standards Codification (“ASC”), as published by the Financial Accounting Standards Board (“FASB”), and with the SEC instructions to Form 10-Q and Article 10 of Regulation S-X. GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. We base these estimates on our experience and assumptions we believe to be reasonable under the circumstances. However, if our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, we may have applied a different accounting treatment, resulting in a different presentation of our financial statements. We periodically reevaluate our estimates and assumptions and, in the event they prove to be different from actual results, we make adjustments in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain.

Our 2025 Annual Report contains additional information regarding the critical accounting policies that affect our more significant estimates and judgments used in the preparation of our Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. There have been no material changes to these policies in 2026.

Recent Accounting Standards

On November 4, 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“DISE”), which requires disaggregated disclosure of income statement expenses for public business entities (“PBEs”). ASU 2024-03 requires PBEs to include footnote disclosure that disaggregates, in a tabular presentation, each relevant expense caption on the face of the income statement that includes certain natural expenses relevant to the Company, such as (i) employee compensation, (ii) depreciation and (iii) intangible asset amortization. The tabular disclosure must also include certain other expenses, when applicable. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. We are evaluating the impact of adopting ASU 2024-03 on our Consolidated Financial Statements.
    
36

Results of Operations

As of June 30, 2026, we operated through three reportable segments: SHOP, OM&R and NNN. In our SHOP segment, we own and invest in senior housing communities and engage operators to operate those communities. In our OM&R segment, we primarily acquire, own, develop, lease and manage outpatient medical buildings and research centers. In our NNN segment, we invest in and own senior housing communities, skilled nursing facilities (“SNFs”), long-term acute care facilities (“LTACs”), freestanding inpatient rehabilitation facilities (“IRFs”) and other healthcare facilities and lease the properties to tenants under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures. Information provided for “non-segment” includes management fees and promote revenues, net of expenses related to our third-party institutional private capital management platform, income from loans and investments and corporate-level expenses not directly attributable to any of our three reportable segments. Non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, loans receivable and investments and accounts receivable.

Our CODM is the Chief Executive Officer of the Company. Our CODM evaluates performance of the combined properties in each operating segment and determines how to allocate resources to these segments, based on NOI for each segment. For further information regarding our reportable segments and a discussion of our definition of NOI, see “Note 16 – Segment Information” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. See “Non-GAAP Financial Measures” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure and reconciliations of Net income attributable to common stockholders, as computed in accordance with GAAP, to NOI.

37

Three Months Ended June 30, 2026 and 2025

The table below shows our results of operations for the three months ended June 30, 2026 and 2025 and the effect of changes in those results from period to period on our Net income attributable to common stockholders (dollars in thousands):

 
For the Three Months Ended June 30,
Increase (Decrease) to Net Income
 
2026
2025
$
%
NOI:
 
 
 
 
SHOP
$
403,499 
$
286,412 
$
117,087 
40.9 
%
OM&R
151,532 
146,486 
5,046 
3.4 
NNN
121,714 
148,736 
(27,022)
(18.2)
Non-segment
8,463 
6,492 
1,971 
30.4 
Total NOI
685,208 
588,126 
97,082 
16.5 
Interest and other income
1,778 
5,871 
(4,093)
(69.7)
Interest expense
(160,034)
(150,298)
(9,736)
(6.5)
Depreciation and amortization
(407,711)
(347,719)
(59,992)
(17.3)
General, administrative and professional fees
(46,986)
(42,856)
(4,130)
(9.6)
Loss on extinguishment of debt, net
(83)
— 
(83)
nm
Transaction, transition and restructuring costs
(13,478)
(4,627)
(8,851)
(191.3)
Other expense
(4,454)
(5,839)
1,385 
nm
Income before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests
54,240 
42,658 
11,582 
27.2 
Loss from unconsolidated entities
(7,812)
(1,138)
(6,674)
nm
Gain on real estate dispositions
176 
33,816 
(33,640)
nm
Income tax benefit (expense)
25,618 
(3,874)
29,492 
761.3 
Net income
72,222 
71,462 
760 
1.1 
Net income attributable to noncontrolling interests
1,652 
3,198 
(1,546)
nm
Net income attributable to common stockholders
$
70,570 
$
68,264 
$
2,306 
nm
______________________________
nm - not meaningful

NOI—SHOP Segment

The following table summarizes results of operations in our SHOP segment for the three months ended June 30, 2026 (dollars in thousands):
 
For the Three Months Ended June 30,
 Increase (Decrease) to NOI
 
2026
2025
$
%
NOI—SHOP:
 
 
 
 
Resident fees and services
$
1,363,498 
$
1,032,714 
$
330,784 
32.0 
%
Less: Property-level operating expenses
(959,999)
(746,302)
(213,697)
(28.6)
NOI
$
403,499 
$
286,412 
$
117,087 
40.9 

Segment Properties at June 30,
Average Unit Occupancy for the Three Months Ended June 30,
Average Monthly Revenue Per Occupied Room for the Three Months Ended June 30,
 
2026
2025
2026
2025
2026
2025
Total communities
813 
683 
88.7 
%
86.5 
%
$
5,629 
$
5,241 
38


Resident fees and services include all amounts earned from residents at the senior housing communities in our SHOP segment, such as rental fees related to resident leases, extended healthcare fees and other ancillary service income. Property-level operating expenses related to our SHOP segment include labor, food, utilities, real estate taxes, insurance, repairs and maintenance, marketing, management fees, supplies and other costs of operating the properties. For senior housing communities in our SHOP segment, occupancy generally reflects average operator-reported unit occupancy for the reporting period. Average monthly revenue per occupied room reflects average resident fees and services per operator-reported occupied unit for the reporting period.

The increase in our SHOP segment NOI for the three months ended June 30, 2026 compared to the same period in 2025 was primarily driven by revenue growth due to an increase in average occupancy, revenue per occupied room, additional properties acquired and conversions of senior housing communities from our NNN segment to our SHOP segment. The revenue increase is partially offset by higher operating expenses in 2026, driven by an increase in the number of communities in our SHOP segment, increase in occupancy and inflation.

The following table compares results of operations for our 567 Same-Store SHOP communities (dollars in thousands). See “Non-GAAP Financial MeasuresNOI” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure regarding Same-Store NOI for each of our reportable business segments.

 
For the Three Months Ended June 30,
Increase (Decrease) to NOI
 
2026
2025
$
%
Same-Store NOI—SHOP:
 
 
 
 
Resident fees and services
$
979,575 
$
902,284 
$
77,291 
8.6 
%
Less: Property-level operating expenses
(674,884)
(640,263)
(34,621)
(5.4)
NOI
$
304,691 
$
262,021 
$
42,670 
16.3 

 
Segment Properties at June 30,
Average Unit Occupancy for the Three Months Ended June 30,
Average Monthly Revenue Per Occupied Room for the Three Months Ended June 30,
 
2026
2025
2026
2025
2026
2025
Same-Store communities
567 
567 
90.9 
%
87.9 
%
$
5,528 
$
5,265 

The increase in our Same-Store SHOP segment NOI for the three months ended June 30, 2026 compared to the same period in 2025 was primarily driven by higher average occupancy and revenue per occupied room, partially offset by higher property-level operating expenses due to higher occupancy and inflation.

39

NOI—OM&R Segment

The following table summarizes results of operations in our OM&R segment for the three months ended June 30, 2026 (dollars in thousands). For properties in our OM&R segment, occupancy generally reflects occupied square footage divided by net rentable square footage as of the end of the reporting period.
For the Three Months Ended June 30,
Increase (Decrease) to NOI
 
2026
2025
$
%
NOI—OM&R:
 
 
 
 
Rental income
$
228,605 
$
220,814 
$
7,791 
3.5 
%
Third-party capital management revenues
708 
673 
35 
5.2 
Total revenues
229,313 
221,487 
7,826 
3.5 
Less:
Property-level operating expenses
(77,781)
(75,001)
(2,780)
(3.7)
NOI
$
151,532 
$
146,486 
$
5,046 
3.4 

Segment Properties at June 30,
 Occupancy at June 30,
Annualized Average Rent Per Occupied Square Foot for the Three Months Ended June 30,
 
2026
2025
2026
2025
2026
2025
Total OM&R
407 
415 
88.5 
%
87.9 
%
$
40 
$
38 

The $5.0 million increase in our OM&R segment NOI for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to new leasing activity, high tenant retention and additional NOI from a development project placed in service, partially offset by higher property-level operating expenses and dispositions.

The following table compares results of operations for our 399 Same-Store OM&R properties (dollars in thousands):
 
For the Three Months Ended June 30,
Increase (Decrease) to NOI
 
2026
2025
$
%
Same-Store NOI—OM&R:
 
 
 
 
Rental income
$
216,834 
$
209,755 
$
7,079 
3.4 
%
Less: Property-level operating expenses
(72,255)
(69,863)
(2,392)
(3.4)
NOI
$
144,579 
$
139,892 
$
4,687 
3.4 

Segment Properties at June 30,
Occupancy at June 30,
Annualized Average Rent Per Occupied Square Foot for the Three Months Ended June 30,
 
2026
2025
2026
2025
2026
2025
Same-Store OM&R
399 
399 
90.0 
%
90.0 
%
$
39 
$
38 

The $4.7 million increase in our Same-Store OM&R segment NOI for the three months ended June 30, 2026 compared to the same period in 2025 is primarily due to new leasing activity and high tenant retention, partially offset by higher property-level operating expenses.

40

NOI—NNN Segment

The following table summarizes results of operations in our 200 NNN segment properties for the three months ended June 30, 2026 (dollars in thousands):
For the Three Months Ended June 30,
(Decrease) Increase to NOI
 
2026
2025
$
%
NOI—NNN:
 
 
 
 
Rental income
$
124,856 
$
152,702 
$
(27,846)
(18.2)
%
Less: Property-level operating expenses
(3,142)
(3,966)
824 
20.8 
NOI
$
121,714 
$
148,736 
$
(27,022)
(18.2)

In our NNN segment, our revenues generally consist of fixed rental amounts (subject to contractual escalations) received from our tenants in accordance with the applicable lease terms. We report revenues and property-level operating expenses within our NNN segment for real estate tax and insurance expenses that are paid from escrows collected from our tenants.

The $27.0 million decrease in our NNN segment NOI for the three months ended June 30, 2026 compared to the same period in 2025 was primarily driven by a $22.1 million decrease in rental income from senior housing communities that converted to our SHOP segment and a $5.9 million decrease in rental income from dispositions.

Occupancy rates may affect the profitability of our tenants’ operations. For senior housing communities and post-acute properties in our NNN segment, occupancy generally reflects average operator-reported unit and bed occupancy, respectively, for the reporting period. Because triple-net occupancy reporting is delivered to us following the reporting period, occupancy is reported in arrears. The following table sets forth average continuing occupancy rates for the trailing 12 months ended March 31, 2026 and 2025 related to the triple-net leased properties we owned and that were included in our NNN segment at June 30, 2026 and 2025, respectively. The table excludes (i) properties classified as held for sale, (ii) non-stabilized properties, (iii) certain properties for which we do not receive occupancy information and (iv) properties acquired or properties that transitioned operators for which we do not have a full quarter of occupancy results.

Number of Properties at June 30, 2026
Average Occupancy for the 12 Months Ended March 31, 2026
Number of Properties at June 30, 2025
Average Occupancy for the 12 Months Ended March 31, 2025
Senior housing communities
117
79.9%
165
78.7%
SNFs
25
80.8
18
86.9
IRFs and LTACs
42
58.2
34
58.5

The following table compares results of operations for our 199 Same-Store NNN segment properties (dollars in thousands):
 
For the Three Months Ended June 30,
Increase (Decrease) to NOI
 
2026
2025
$
%
Same-Store NOI—NNN:
 
 
 
 
Rental income
$
124,856 
$
123,407 
$
1,449 
1.2 
%
Less: Property-level operating expenses
(3,141)
(2,906)
(235)
(8.1)
NOI
$
121,715 
$
120,501 
$
1,214 
1.0 

The increase in our Same-Store NNN segment rental income for the three months ended June 30, 2026 compared to the same period in 2025 was attributable primarily due to contractual rent escalators.
41

NOI—Non-Segment

Non-segment NOI includes management fees and promote revenues, net of expenses, related to our third-party institutional private capital management platform, income from loans and investments and corporate-level expenses not directly attributable to any of our three reportable business segments. The $2.0 million increase in non-segment NOI for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to interest income from a new secured loan investment.

Corporate Results

Interest and other income

The $4.1 million decrease in Interest and other income for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to a decrease in overall cash and cash equivalents invested in short-term money market funds.

Interest expense

The $9.7 million increase in Interest expense for the three months ended June 30, 2026 compared to the same period in 2025 was driven primarily by an increase in the weighted average debt outstanding. Our weighted average debt outstanding was $13.5 billion and $13.0 billion for the three months ended June 30, 2026 and 2025, respectively. Total debt decreased from $13.0 billion as of December 31, 2025 to $12.7 billion as of June 30, 2026. Our weighted average effective interest rate was 4.59% and 4.55% for the three months ended June 30, 2026 and 2025, respectively.

Depreciation and amortization

The $60.0 million increase in Depreciation and amortization expense for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to an increase of $64.1 million associated with recent acquisition activities in 2026 compared to 2025.
    
General, administrative and professional fees

The $4.1 million increase in General, administrative and professional fees for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to an increase in investments and strategic initiatives and to scale our employee base in support of our growing enterprise.

Transaction, transition and restructuring costs

The $8.9 million increase in Transaction, transition and restructuring costs for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to a $6.2 million increase in transaction costs.

Other expense

The $1.4 million decrease in Other expense for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to lower insurance related expenses, net of insurance proceeds, partially offset by mark to market adjustments to our derivative instruments in 2025.

Loss from unconsolidated entities

The $6.7 million increase in Loss from unconsolidated entities for the three months ended June 30, 2026 compared to the same period in 2025 was primarily due to higher depreciation and amortization expense and interest expense due to assets being placed in service.

Gain on real estate dispositions

For the three months ended June 30, 2026, we sold 3 properties for a $0.2 million gain. For the three months ended June 30, 2025, we sold 10 properties and recognized a $13.2 million gain.
42


Income tax benefit (expense)

The $25.6 million income tax benefit for the three months ended June 30, 2026 is primarily due to the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities, partially offset by increases in the valuation allowance for certain TRS entities during the period. The $3.9 million income tax expense for the three months ended June 30, 2025 was primarily due to certain of our TRS entities incurring tax expense as a result of interest expense in excess of certain deduction thresholds, partially offset by the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities.

Six Months Ended June 30, 2026 and 2025

The table below shows our results of operations for the six months ended June 30, 2026 and 2025 and the effect of changes in those results from period to period on our Net income attributable to common stockholders (dollars in thousands):

For the Six Months Ended June 30,
Increase (Decrease) to Net Income
 
2026
2025
$
%
NOI:
 
 
 
 
SHOP
$
777,957 
$
550,916 
$
227,041 
41.2 
%
OM&R
302,135 
292,528 
9,607 
3.3 
NNN
241,884 
301,322 
(59,438)
(19.7)
Non-segment
14,310 
12,647 
1,663 
13.1 
Total NOI
1,336,286 
1,157,413 
178,873 
15.5 
Interest and other income
4,277 
8,949 
(4,672)
(52.2)
Interest expense
(316,176)
(299,654)
(16,522)
(5.5)
Depreciation and amortization
(790,179)
(669,244)
(120,935)
(18.1)
General, administrative and professional fees
(109,732)
(96,005)
(13,727)
(14.3)
Loss on extinguishment of debt, net
(532)
— 
(532)
nm
Transaction, transition and restructuring costs
(20,137)
(10,609)
(9,528)
(89.8)
Other expense
(14,154)
(7,251)
(6,903)
(95.2)
Income before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests
89,653 
83,599 
6,054 
nm
Loss from unconsolidated entities
(15,162)
(4,449)
(10,713)
nm
Gain on real estate dispositions
15,222 
33,985 
(18,763)
(55.2)
Income tax benefit
41,555 
6,683 
34,872 
nm
Net income
131,268 
119,818 
11,450 
nm
Net income attributable to noncontrolling interests
4,786 
4,686 
100 
2.1 
Net income attributable to common stockholders
$
126,482 
$
115,132 
$
11,350 
nm
______________________________
nm - not meaningful

43

NOI—SHOP Segment

The following table summarizes results of operations in our SHOP segment for the six months ended June 30, 2026 (dollars in thousands):
For the Six Months Ended June 30,
Increase (Decrease) to NOI
2026
2025
$
%
NOI—SHOP:
Resident fees and services
$
2,656,288 
$
2,001,618 
$
654,670 
32.7 
%
Less: Property-level operating expenses
(1,878,331)
(1,450,702)
(427,629)
(29.5)
NOI
$
777,957 
$
550,916 
$
227,041 
41.2 

Segment Properties at June 30,
Average Unit Occupancy for the Six Months Ended June 30,
 Average Monthly Revenue Per Occupied Room for the Six Months Ended June 30,
2026
2025
2026
2025
2026
2025
Total communities
813 
683 
88.6 
%
86.3 
%
$
5,601 
$
5,188 

The increase in our SHOP segment NOI for the six months ended June 30, 2026 compared to the same period in 2025 was primarily driven by revenue growth due to an increase in average occupancy, revenue per occupied room, additional properties acquired and conversions of senior housing communities from our NNN segment to our SHOP segment. The revenue increase is partially offset by higher operating expenses in 2026, driven by an increase in the number of communities in our SHOP segment, increase in occupancy and inflation.

The following table compares results of operations for our 550 Same-Store SHOP communities (dollars in thousands). See “Non-GAAP Financial MeasuresNOI” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure regarding Same-Store NOI for each of our reportable business segments.

For the Six Months Ended June 30,
Increase (Decrease) to NOI
2026
2025
$
%
Same-Store NOI—SHOP:
Resident fees and services
$
1,878,336 
$
1,728,612 
$
149,724 
8.7 
%
Less: Property-level operating expenses
(1,304,903)
(1,234,040)
(70,863)
(5.7)
NOI
$
573,433 
$
494,572 
$
78,861 
15.9 

Segment Properties at June 30,
Average Unit Occupancy for the Six Months Ended June 30,
 Average Monthly Revenue Per Occupied Room for the Six Months Ended June 30,
2026
2025
2026
2025
2026
2025
Same-Store communities
550 
550 
90.7 
%
87.6 
%
$
5,507 
$
5,247 

The increase in our Same-Store SHOP segment NOI for the six months ended June 30, 2026 compared to the same period in 2025 was primarily driven by higher average occupancy and revenue per occupied room, partially offset by higher property-level operating expenses due to higher occupancy and inflation.

44

NOI—OM&R Segment

The following table summarizes results of operations in our OM&R segment for the six months ended June 30, 2026 (dollars in thousands). For properties in our OM&R segment, occupancy generally reflects occupied square footage divided by net rentable square footage as of the end of the reporting period.

For the Six Months Ended June 30,
Increase (Decrease) to NOI
2026
2025
$
%
NOI—OM&R:
Rental income
$
458,709 
$
442,133 
$
16,576 
3.7 
%
Third-party capital management revenues
1,508 
1,353 
155 
11.5 
Total revenues
460,217 
443,486 
16,731 
3.8 
Less:
Property-level operating expenses
(158,082)
(150,958)
(7,124)
(4.7)
NOI
$
302,135 
$
292,528 
$
9,607 
3.3 

Segment Properties at June 30,
Occupancy at June 30,
Annualized Average Rent Per Occupied Square Foot for the Six Months Ended June 30,
2026
2025
2026
2025
2026
2025
Total OM&R
407 
415 
88.5 
%
87.9 
%
$
40 
$
38 
    
The $9.6 million increase in our OM&R segment NOI for the six months ended June 30, 2026 compared to the same period in 2025 was primarily due to new leasing activity, high tenant retention and additional NOI from a development project placed in service, partially offset by higher property-level operating expenses and dispositions.

The following table compares results of operations for our 399 Same-Store OM&R properties (dollars in thousands):
For the Six Months Ended June 30,
Increase (Decrease) to NOI
2026
2025
$
%
Same-Store NOI—OM&R:
Rental income
$
435,094 
$
420,724 
$
14,370 
3.4 
%
Less: Property-level operating expenses
(146,844)
(140,469)
(6,375)
(4.5)
NOI
$
288,250 
$
280,255 
$
7,995 
2.9 

Segment Properties at June 30,
Occupancy at June 30,
Annualized Average Rent Per Occupied Square Foot for the Six Months Ended June 30,
2026
2025
2026
2025
2026
2025
Same-Store OM&R
399 
399 
90.0 
%
90.0 
%
$
39 
$
38 
    
The $8.0 million increase in our Same-Store OM&R segment NOI for the six months ended June 30, 2026 compared to the same period in 2025 is primarily due to new leasing activity and high tenant retention, partially offset by higher property-level operating expenses.

45

NOI— NNN Segment

The following table summarizes results of operations in our 200 NNN segment properties for the six months ended June 30, 2026 (dollars in thousands):
For the Six Months Ended June 30,
(Decrease) Increase to NOI
2026
2025
$
%
NOI—NNN:
Rental income
$
247,927 
$
308,815 
$
(60,888)
(19.7)
%
Less: Property-level operating expenses
(6,043)
(7,493)
1,450 
19.4 
NOI
$
241,884 
$
301,322 
$
(59,438)
(19.7)

The $59.4 million decrease in our NNN segment NOI for the six months ended June 30, 2026 compared to the same period in 2025 was primarily driven by a $46.7 million decrease in rental income from senior housing communities that converted to our SHOP segment and a $15.4 million decrease in rental income from dispositions.

The following table compares results of operations for our 199 Same-Store NNN segment properties (dollars in thousands):
For the Six Months Ended June 30,
Increase to NOI
2026
2025
$
%
Same-Store NOI—NNN:
Rental income
$
247,956 
$
245,069 
$
2,887 
1.2 
%
Less: Property-level operating expenses
(6,042)
(6,206)
164 
2.6 
NOI
$
241,914 
$
238,863 
$
3,051 
1.3 

The increase in our Same-Store NNN segment rental income for the six months ended June 30, 2026 compared to the same period in 2025 was attributable primarily to contractual rent escalators.

NOI—Non-Segment

The $1.7 million increase in non-segment NOI for the six months ended June 30, 2026 compared to the same period in 2025 was primarily due to interest income from a new secured loan investment.

Corporate Results

Interest and other income

The $4.7 million decrease in Interest and other income for the six months ended June 30, 2026 compared to the same period in 2025 was primarily due to a decrease in overall cash and cash equivalents invested in short-term money market funds.

Interest expense

The $16.5 million increase in Interest expense, net of capitalized interest for the six months ended June 30, 2026 compared to the same period in 2025 was driven primarily by higher rates and a higher overall debt balance. Our weighted average effective interest rate was 4.59% and 4.51% for the six months ended June 30, 2026 and 2025, respectively. Our weighted average debt outstanding was $13.4 billion and $13.1 billion for the six months ended June 30, 2026 and 2025, respectively. Total debt decreased from $13.0 billion as of December 31,2025 to $12.7 billion as of June 30, 2026.

46

Depreciation and amortization

The $120.9 million increase in Depreciation and amortization expense for the six months ended June 30, 2026 compared to the same period in 2025 was primarily due to $118.8 million associated with recent acquisition activities in 2026 compared to 2025.

General, administrative and professional fees

The $13.7 million increase in General, administrative and professional fees for the six months ended June 30, 2026 compared to the same period in 2025 was primarily due to an increase in investments and strategic initiatives and to scale our employee base in support of our growing enterprise.

Transaction, transition and restructuring costs

The $9.5 million increase in Transaction, transition and restructuring costs for the six months ended June 30, 2026 compared to the same period in 2025 was primarily due to a $6.4 million increase in transaction costs.

Other expense

The $6.9 million increase in Other expense for the six months ended June 30, 2026 compared to the same period in 2025 was primarily due to mark to market adjustments to our derivative instruments in 2025, partially offset by lower net insurance costs.

Loss from unconsolidated entities

The $10.7 million increase in Loss from unconsolidated entities for the six months ended June 30, 2026 compared to the same period in 2025 is primarily due to higher depreciation and amortization expense and interest expense due to assets being placed in service.

Gain on real estate dispositions

For the six months ended June 30, 2026, we sold 15 properties for a gain of $15.2 million. For the six months ended June 30, 2025, we sold 11 properties for a gain of $13.2 million and entered into a sales-type lease which resulted in a gain of $20.8 million.

Income tax benefit

The $41.6 million of income tax benefit for the six months ended June 30, 2026 was primarily due to the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities, partially offset by increases in the valuation allowance for certain TRS entities during the periods. The $6.7 million of income tax benefit for the six months ended June 30, 2025 was primarily due to the reversal of valuation allowances recorded against the net deferred tax assets of certain of our TRS entities.

Non-GAAP Financial Measures

We consider certain non-GAAP financial measures to be useful supplemental measures of our operating performance. A non-GAAP financial measure is a measure of historical or future financial performance, financial position or cash flows that excludes or includes amounts that are not so excluded from or included in the most directly comparable measure calculated and presented in accordance with GAAP. Described below are the non-GAAP financial measures used by management to evaluate our operating performance and that we consider most useful to investors, together with reconciliations of these measures to the most directly comparable GAAP measures.

47

The non-GAAP financial measures we present in this Quarterly Report on Form 10-Q may not be comparable to those presented by other companies, which may define similarly titled measures differently than we do. You should not consider these measures as alternatives for, or superior to, financial measures calculated in accordance with GAAP. In order to facilitate a clear understanding of our consolidated historical operating results, you should examine these measures in conjunction with the most directly comparable GAAP measures as presented in our Consolidated Financial Statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q.

Nareit Funds From Operations and Normalized Funds From Operations Attributable to Common Stockholders

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, since real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, we consider Nareit Funds From Operations attributable to common stockholders (“FFO”) and Normalized FFO attributable to common stockholders (“Normalized FFO”) to be appropriate supplemental measures of operating performance of an equity REIT. We believe that the presentation of FFO, combined with the presentation of required GAAP financial measures, has improved the understanding of operating results of REITs among the investing public and has helped make comparisons of REIT operating results more meaningful. Management generally considers FFO to be a useful measure for understanding and comparing our operating results because, by excluding gains and losses related to sales of previously depreciated operating real estate assets, impairment losses on depreciable real estate and real estate asset depreciation and amortization (which can differ across owners of similar assets in similar condition based on historical cost accounting and useful life estimates), FFO can help investors compare the operating performance of a company’s real estate across reporting periods and to the operating performance of other companies. We believe that Normalized FFO is useful because it allows investors, analysts and our management to compare our operating performance across periods on a consistent basis. In some cases, we provide information about identified non-cash components of FFO and Normalized FFO because it allows investors, analysts and our management to assess the impact of those items on our financial results.

We use the National Association of Real Estate Investment Trusts (“Nareit”) definition of FFO. Nareit defines FFO as net income attributable to common stockholders (computed in accordance with GAAP) excluding gains (or losses) from sales of real estate property, including gain (or loss) on re-measurement of equity method investments and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests. Adjustments for unconsolidated entities and noncontrolling interests will be calculated to reflect FFO on the same basis. We define Normalized FFO as Nareit FFO excluding the following income and expense items, without duplication: (a) gains and losses on derivatives, net and changes in the fair value of financial instruments; (b) the non-cash impact of income tax benefits or expenses; (c) gains and losses on extinguishment of debt, net including the write-off of unamortized deferred financing fees or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of our debt; (d) transaction, transition and restructuring costs; (e) amortization of other intangibles; (f) non-cash stock-based compensation expense; (g) net expenses or recoveries related to significant disruptive events; (h) the impact of expenses related to asset impairment and valuation allowances; (i) the financial impact of contingent consideration; (j) gains and losses on non-real estate dispositions and other normalizing items related to noncontrolling interests and unconsolidated entities; and (k) other items set forth in the Normalized FFO reconciliation included herein.

48

The following table summarizes our FFO and Normalized FFO for the three and six months ended June 30, 2026 and 2025 (dollars in thousands):

 
For the Three Months Ended June 30,
For the Six Months Ended June 30,
 
2026
2025
2026
2025
Net income attributable to common stockholders
$
70,570 
$
68,264 
$
126,482 
$
115,132 
Adjustments:
 
Depreciation and amortization on real estate assets
406,036 
346,214 
786,848 
666,413 
Depreciation on real estate assets related to noncontrolling interests
(6,238)
(3,973)
(10,493)
(8,144)
Depreciation on real estate assets related to unconsolidated entities
22,600 
18,716 
44,699 
34,711 
Gain on real estate dispositions
(176)
(33,816)
(15,222)
(33,985)
Loss (gain) on real estate dispositions related to unconsolidated entities
29 
(62)
63 
(25)
Nareit FFO attributable to common stockholders
492,821 
395,343 
932,377 
774,102 
Adjustments:
 
 
Loss (gain) on derivatives, net
100 
(1,074)
(14)
(9,458)
Non-cash impact of income tax (benefit) expense
(29,017)
748 
(48,255)
(13,032)
Loss on extinguishment of debt, net
83 
— 
532 
— 
Transaction, transition and restructuring costs
13,478 
4,627 
20,137 
10,609 
Amortization of other intangibles
119 
121 
238 
243 
Non-cash stock-based compensation expense (1)
5,312 
7,683 
30,154 
26,509 
Significant disruptive events, net
(1,064)
958 
1,121 
5,024 
Normalizing items related to noncontrolling interests and unconsolidated entities, net
1,884 
463 
3,044 
949 
Other normalizing items, net
— 
(1)
— 
(1)
Normalized FFO attributable to common stockholders (1)
$
483,716 
$
408,868 
$
939,334 
$
794,945 
______________________________
(1)Beginning with the first quarter of 2026, the Company excludes non-cash stock-based compensation expense from the calculation of Normalized FFO. Results for prior periods have been updated to conform to this presentation.
NOI

We consider NOI an important supplemental measure because it allows investors, analysts and our management to assess our unlevered property-level operating results and to compare our operating results between periods on a consistent basis. We define NOI as total revenues, less interest and other income, property-level operating expenses and third-party capital management expenses. In order to facilitate a clear understanding of our historical consolidated operating results, NOI should be examined in conjunction with Net income attributable to common stockholders as presented in our Consolidated Financial Statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q.

49

The following table sets forth a reconciliation of Net income attributable to common stockholders to NOI (dollars in thousands):
 
For the Three Months Ended June 30,
For the Six Months Ended June 30,
 
2026
2025
2026
2025
Net income attributable to common stockholders
$
70,570 
$
68,264 
$
126,482 
$
115,132 
Adjustments:
Interest and other income
(1,778)
(5,871)
(4,277)
(8,949)
Interest expense
160,034 
150,298 
316,176 
299,654 
Depreciation and amortization
407,711 
347,719 
790,179 
669,244 
General, administrative and professional fees
46,986 
42,856 
109,732 
96,005 
Loss on extinguishment of debt, net
83 
— 
532 
— 
Transaction, transition and restructuring costs
13,478 
4,627 
20,137 
10,609 
Other expense
4,454 
5,839 
14,154 
7,251 
Net income attributable to noncontrolling interests
1,652 
3,198 
4,786 
4,686 
Loss from unconsolidated entities
7,812 
1,138 
15,162 
4,449 
Gain on real estate dispositions
(176)
(33,816)
(15,222)
(33,985)
Income tax (benefit) expense
(25,618)
3,874 
(41,555)
(6,683)
NOI
$
685,208 
$
588,126 
$
1,336,286 
$
1,157,413 

See “Results of Operations” for discussions regarding both NOI and Same-Store NOI. We define Same-Store as properties owned, consolidated and operational for the full period in both comparison periods and that are not otherwise excluded; provided, however, that we may include selected properties that otherwise meet the Same-Store criteria if they are included in substantially all of, but not a full, period for one or both of the comparison periods, and in our judgment such inclusion provides a more meaningful presentation of our segment performance.

Newly acquired development properties and recently developed or redeveloped properties in our SHOP reportable segment will be included in Same-Store once they are stabilized for the full period in both periods presented. These properties are considered stabilized upon the earlier of (a) the achievement of 80% sustained occupancy or (b) 24 months from the date of acquisition or substantial completion of work. Recently developed or redeveloped properties in our OM&R and NNN reportable segments will be included in Same-Store once substantial completion of work has occurred for the full period in both periods presented. Our SHOP and NNN properties that have undergone operator or business model transitions will be included in Same-Store once operating under consistent operating structures for the full period in both periods presented.

Properties are excluded from Same-Store if they are: (i) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (ii) impacted by significant disruptive events such as flood or fire; (iii) for SHOP, those properties that are currently undergoing a significant disruptive redevelopment; (iv) for OM&R and NNN reportable segments, those properties for which management has an intention to institute, or has instituted, a redevelopment plan because the properties may require major property-level expenditures to maximize value, increase NOI, or maintain a market-competitive position and/or achieve property stabilization, most commonly as the result of an expected or actual material change in occupancy or NOI; or (v) for SHOP and NNN reportable segments, those properties that are scheduled to undergo operator or business model transitions, or have transitioned operators or business models after the start of the prior comparison period.        

To eliminate the impact of exchange rate movements, our same-store NOI and same-store SHOP communities average monthly revenue per occupied room (RevPor) performance-based disclosures assume constant exchange rates across comparable periods using the following methodology: the current period’s results are shown in actual reported USD, while prior comparison period’s results are adjusted and converted to USD based on the average monthly exchange rate for the current period.

50

The following table shows the same-store metrics for the prior year’s results with and without the impact from applying a constant exchange rate:

For the Three Months Ended June 30, 2025
Constant Exchange Rate
Without Constant Exchange Rate
Same-Store NOI—SHOP
Resident fees and services
$
902,284
$
902,402
Less: Property-level operating expenses
(640,263)
(640,301)
NOI
$
262,021
$
262,101
Same-Store NOI—NNN
Rental income
$
123,407
$
123,389
Less: Property-level operating expenses
(2,906)
(2,906)
NOI
$
120,501
$
120,483

For the Three Months Ended June 30, 2025
Constant Exchange Rate
Without Constant Exchange Rate
Same-Store RevPor - SHOP Communities
$
5,265
$
5,266


For the Six Months Ended June 30, 2025
Constant Exchange Rate
Without Constant Exchange Rate
Same-Store NOI—SHOP
Resident fees and services
$
1,728,612
$
1,723,114
Less: Property-level operating expenses
(1,234,040)
(1,230,717)
NOI
$
494,572
$
492,397
Same-Store NOI—NNN
Rental income
$
245,069
$
244,792
Less: Property-level operating expenses
(6,206)
(6,206)
NOI
$
238,863
$
238,586

For the Six Months Ended June 30, 2025
Constant Exchange Rate
Without Constant Exchange Rate
Same-Store RevPor - SHOP Communities
$
5,247
$
5,230


51

Concentration Risk

We use concentration ratios to identify, understand and evaluate the potential impact of economic downturns and other adverse events that may affect our asset types, geographic locations, business models, and managers, tenants and borrowers. We evaluate concentration risk in terms of investment mix and operations mix. Investment mix measures the percentage of our investments that is concentrated in a specific asset type or that is operated or managed by a particular manager, tenant or borrower. Operations mix measures the percentage of our operating results that is attributed to a particular manager, tenant or borrower, geographic location or business model. See “Note 3 – Concentration of Credit Risk” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure on the concentration of our credit risk.

The following tables reflect our concentration risk as of the dates and for the periods presented:

As of June 30, 2026
As of December 31, 2025
Investment mix by asset type (1):
 
 
Senior housing communities
71.1 
%
69.2 
%
Outpatient medical buildings
16.6 
18.2 
Research centers
5.1 
5.6 
Other healthcare facilities
3.9 
4.1 
Inpatient rehabilitation facilities (“IRFs”) and long-term acute care facilities (“LTACs”)
1.6 
1.8 
Skilled nursing facilities (“SNFs”)
0.6 
0.7 
Secured loans receivable and investments, net
1.1 
0.4 
Total
100.0 
%
100.0 
%
Investment mix by manager and tenant (1):
 
 
Atria
17.9 
%
19.6 
%
Lillibridge
8.8 
9.5 
Sunrise
8.6 
9.3 
Discovery
7.1 
5.4 
Le Groupe Maurice
5.6 
6.2 
Wexford
4.9 
5.3 
Ardent
4.1 
4.5 
PMB RES
3.7 
4.0 
All other
39.3 
36.2 
Total
100.0 
%
100.0 
%
______________________________
(1)Ratios are based on the gross book value of consolidated real estate investments (excluding properties classified as held for sale, development properties not yet operational and land parcels and including secured loan receivable and investments, net) as of each reporting date.



52

 
For the Three Months Ended June 30,
For the Six Months Ended June 30,
 
2026
2025
2026
2025
Operations mix by manager and tenant and business model:
 
 
Total Revenues:
 
 
SHOP
78.8 
%
72.7 
%
78.4 
%
72.0 
%
Ardent
2.3 
2.7 
2.3 
2.8 
Kindred (1)
2.0 
2.5 
2.0 
2.6 
All others
16.9 
22.1 
17.3 
22.6 
Total
100.0 
%
100.0 
%
100.0 
%
100.0 
%
Net operating income (“NOI”):
SHOP
58.9 
%
48.7 
%
58.2 
%
47.6 
%
Ardent
5.7 
6.5 
5.9 
6.6 
Kindred (1)
5.1 
5.9 
5.2 
6.1 
All other
30.3 
38.9 
30.7 
39.7 
Total
100.0 
%
100.0 
%
100.0 
%
100.0 
%
Operations mix by geographic location:
 
Total Revenues:
California
11.5 
%
12.5 
%
11.6 
%
12.7 
%
Texas
9.1 
8.2 
9.0 
7.7 
New York
7.9 
6.8 
7.9 
6.9 
Quebec, Canada
4.7 
5.4 
4.8 
5.4 
Florida
5.1 
3.6 
4.8 
3.6 
All others
61.7 
63.5 
61.9 
63.7 
Total
100.0 
%
100.0 
%
100.0 
%
100.0 
%
______________________________
(1)     Includes financial impact from leasing and loan agreements with Kindred.

See “Non-GAAP Financial Measures” included elsewhere in this Quarterly Report on Form 10-Q for additional disclosure and reconciliations of Net income attributable to common stockholders, as computed in accordance with GAAP, to NOI.

Triple-Net Lease Performance and Expirations

Any failure, inability or unwillingness by our tenants to satisfy their obligations under our triple-net leases could have a material adverse effect on us. Also, if our tenants are not able or willing to renew our triple-net leases upon expiration, we may be unable to reposition the applicable properties on a timely basis or on the same or better economic terms, if at all. Although our lease expirations are staggered, the non-renewal of some or all of our triple-net leases that expire in any given year could have a material adverse effect on us. During the six months ended June 30, 2026, we had no triple-net lease expirations that, in the aggregate, had a material impact on our financial condition or results of operations for that period.

53

Tenant Lease Expirations

The following table summarizes our lease expirations in our OM&R and NNN segments, excluding real estate assets classified as held for sale, over the next 10 years and thereafter, assuming that none of the tenants exercise any of their renewal or purchase options, as of June 30, 2026 (dollars and square feet in thousands):

Expiration Year
Remainder of 2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Thereafter
OM&R:
Square Feet
1,345
2,826
2,547
2,562
2,371
1,858
1,546
1,251
2,538
841
2,296
OM&R Annualized Base Rent (1)
$39,015
$87,763
$76,044
$76,130
$68,938
$46,510
$46,576
$39,359
$71,151
$23,631
$62,524
% of Total OM&R Annualized Base Rent
%
14 
%
12 
%
12 
%
11 
%
%
%
%
11 
%
%
10 
%
NNN:
Segment Properties
11
6
10
18
7
20
7
4
0
80
36
NNN Annualized Base Rent (1)(2)
$11,519
$10,795
$18,127
$12,248
$7,312
$30,106
$9,271
$1,570
$0
$214,799
$145,497
% of Total NNN Annualized Base Rent
%
%
%
%
%
%
%
— 
%
— 
%
47 
%
32 
%
Total OM&R and NNN Annualized Base Rent
$50,534
$98,558
$94,170
$88,377
$76,250
$76,616
$55,847
$40,930
$71,151
$238,430
$208,021
% of Total OM&R and NNN Annualized Base Rent
%
%
%
%
%
%
%
%
%
22 
%
19 
%
______________________________
(1)Annualized Base Rent (“ABR”) represents the annualized contractual cash base rent as of quarter end. ABR does not include future rent escalators, percentage rent, which is a rental charge typically based on certain tenants' gross revenue, common area maintenance charges or non-cash items such as straight-line rental income, the amortization of above / below market lease intangibles or other items.

(2)The expiration of ABR in 2035 includes rent associated with 65 properties currently leased to Brookdale. See “Risk Factors—Risks Relating to Our Business Operations and Strategy—Our inability to renew our management agreements with our SHOP managers or our leases with our NNN and OM&R tenants on as favorable terms or at all, and our inability when necessary, to effectively and efficiently transition a SHOP community to a new manager or a NNN or OM&R property to a new tenant, may have an adverse effect on our business, financial condition and results of operations” included in Part I, Item 1A of our 2025 Annual Report.

Liquidity and Capital Resources     

Our principal sources of liquidity are cash flows from operations, proceeds from the issuance of debt and equity securities, borrowings under our unsecured revolving credit facility and commercial paper program, and proceeds from asset sales.

54

For the next 12 months, our principal liquidity needs are to: (i) fund operating expenses; (ii) meet our debt service requirements; (iii) repay maturing mortgage and other debt; (iv) fund acquisitions, investments and commitments and any development and redevelopment activities; (v) fund capital expenditures; and (vi) make distributions to our stockholders and unitholders, as required for us to continue to qualify as a REIT. Depending upon the availability of external capital, we believe our liquidity is sufficient to fund these uses of cash. We expect that these liquidity needs generally will be satisfied by a combination of the following: cash flows from operations, cash on hand, unsettled equity forward sales agreements, debt assumptions and financings (including secured financings), issuances of debt and equity securities, dispositions of assets (including, in whole or in part, through joint venture arrangements) and borrowings under our revolving credit facility and commercial paper program. However, an inability to access liquidity through multiple capital sources concurrently could have a material adverse effect on us.

Our material contractual obligations arising in the normal course of business primarily consist of long-term debt and related interest payments, and operating obligations which include ground lease obligations. During the six months ended June 30, 2026, our material contractual obligations decreased primarily due to the net repayment of debt. See “Note 10 – Senior Notes Payable and Other Debt” and “Note 12 – Commitments and Contingencies” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for further information regarding our long-term debt obligations and operating obligations, respectively.

We may, from time to time, seek to retire or purchase our outstanding indebtedness for cash or in exchange for equity securities in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, prospects for capital and other factors. The amounts involved may be material.

Credit Facilities, Commercial Paper, Unsecured Term Loans and Letters of Credit

As of June 30, 2026, our $3.5 billion unsecured revolving credit facility had no borrowings outstanding and $0.8 million restricted to support outstanding letters of credit. We use our unsecured revolving credit facility to support our commercial paper program and for general corporate purposes.

Our wholly-owned subsidiary, VRLP, may issue from time to time unsecured commercial paper notes up to a maximum aggregate amount outstanding at any time of $2.5 billion. The notes are sold under customary terms in the U.S. commercial paper note market and are ranked pari passu with VRLP’s other unsecured senior indebtedness. The notes are fully and unconditionally guaranteed by Ventas. As of June 30, 2026 and December 31, 2025, we had $265.0 million and no borrowings, respectively, outstanding under our commercial paper program.

As of June 30, 2026, VRLP had an unsecured term loan in aggregate principal of $1.25 billion. The term loan is priced at SOFR plus 0.85%, which is subject to adjustment based on VRLP’s debt ratings. This term loan is fully and unconditionally guaranteed by Ventas and subject to certain customary covenants and other terms and conditions. It is scheduled to mature in January 2031 and includes an accordion feature that permits VRLP to increase the aggregate borrowings thereunder to up to $1.75 billion, subject to the satisfaction of certain conditions, including the receipt of additional commitments for such increase.

As of June 30, 2026, we had a $100.0 million uncommitted line for standby letters of credit, which had an outstanding balance of $28.2 million. The agreement governing the line contains certain customary covenants and other terms and conditions. Under its terms, we are required to pay a fixed rate commission on each outstanding letter of credit.

55

Exchangeable Senior Notes

In June 2023, VRLP issued $862.5 million aggregate principal amount of its 3.75% Exchangeable Senior Notes due 2026 (the “Exchangeable Notes”) in a private placement. The Exchangeable Notes were senior, unsecured obligations of VRLP and fully and unconditionally guaranteed on an unsecured and unsubordinated basis by Ventas. The Exchangeable Notes bore interest at a rate of 3.75% per year, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2023. The Exchangeable Notes matured in June 2026, and in accordance with the terms of the governing indenture, we settled the outstanding aggregate principal amount of the Exchange Notes with $856.1 million in cash and the conversion premium by issuing 5.9 million of Ventas common stock.

During the three and six months ended June 30, 2026, we recognized $5.2 million and $13.2 million, respectively, of contractual interest expense and amortization of issuance costs of $1.2 million and $3.1 million, respectively, related to the Exchangeable Notes.

Senior Notes

In January 2026, we repaid $500.0 million aggregate principal amount of 4.13% Senior Notes due 2026.

Mortgages

During the six months ended June 30, 2026, we used the proceeds from a new mortgage loan with a principal amount of C$92.0 million ($67.4 million) maturing in February 2031 to refinance an existing mortgage loan with a principal amount of C$87.1 million ($63.8 million).

During the three months ended June 30, 2026, in connection with certain of our senior housing acquisitions, we incurred $333.7 million of mortgage loans with maturities ranging from August 2029 to May 2031.

Derivatives and Hedging

In the normal course of our business, interest rate fluctuations affect future cash flows under our variable rate debt obligations, loans receivable and marketable debt securities, and foreign currency exchange rate fluctuations affect our operating results. We follow established risk management policies and procedures, including the use of derivative instruments, to mitigate the impact of these risks.

We do not use derivative instruments for trading or speculative purposes, and we have a policy of entering into contracts only with major financial institutions based upon their credit ratings and other factors. When considered together with the underlying exposure that the derivative is designed to hedge, we do not expect that the use of derivatives in this manner would have any material adverse effect on our future financial condition or results of operations.

We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and variable-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements are used to hedge the variable cash flows associated with variable-rate debt.

Periodically, we enter into interest rate derivatives, such as treasury locks, to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized over the life of the related debt and recorded in Interest expense in our Consolidated Statements of Income.

As of June 30, 2026, our variable rate debt obligations of $1.9 billion reflect, in part, the effect of $74.4 million notional amount of interest rate swaps with maturities in March 2027, that effectively convert fixed rate debt to variable rate debt. These interest rate swaps were not designated for hedge accounting.
56


As of June 30, 2026, our fixed rate debt obligations of $10.8 billion reflect, in part, the effect of $125.1 million and C$587.6 million ($414.0 million) notional amount of interest rate swaps with maturities ranging from June 2027 to April 2031, that effectively convert variable rate debt to fixed rate debt. These interest rate swaps were designated as cash flow hedges.

2026 Activity

During the three and six months ended June 30, 2026, approximately $0.2 million and $0.7 million, respectively, of realized losses primarily relating to our interest rate swaps and treasury locks were reclassified into Interest expense in our Consolidated Statements of Income. Approximately $0.3 million of unrealized gains, which are included in Accumulated other comprehensive income as of June 30, 2026, are expected to be reclassified into earnings within the next 12 months.

Capital Stock

Equity Forward Sales Agreements

In May 2026, we amended the existing ATM Program such that the aggregate gross sales price of common stock available for issuance increased from $2.5 billion to $3.0 billion. As of June 30, 2026, the remaining amount available under the ATM Program for future sales of common stock was $2.3 billion.

During the three months ended June 30, 2026, we entered into equity forward sales agreements under the ATM Program for 20.9 million shares of our common stock for gross proceeds of $1.8 billion, representing an average price of $86.94 per share. During the three months ended June 30, 2026, we settled 20.8 million shares of common stock under outstanding equity forward sales agreements entered into under the ATM Program for net cash proceeds of $1.7 billion.

In July 2026, we entered into equity forward sales agreements under the ATM Program for 1.3 million shares of common stock or approximately $119.7 million in gross proceeds which remain unsettled with maturity in December 2027. As of July 30, 2026, the remaining amount available under the ATM Program for future sales of common stock was $2.0 billion, and we maintained unsettled equity forward sales agreements of 18.5 million shares of common stock, or approximately $1.6 billion in gross proceeds, with varying maturities through December 2027.

From time to time, including under the ATM Program, we may enter into equity forward sales agreements. An equity forward sales agreement enables us to secure a share price on the sale of shares of our common stock at or shortly after the time the forward sales agreement becomes effective, while postponing the receipt of proceeds from the sale of shares until a future date. Equity forward sales agreements generally have a maturity of one to two years. At any time during the term of an equity forward sales agreement, we may settle that equity forward sales agreement by delivery of physical shares of our common stock to the forward purchaser or, at our election, subject to certain exceptions, we may settle in cash or by net share settlement. The forward sales price we expect to receive upon settlement of outstanding equity forward sales agreements will be the initial forward price, net of commissions, established on or shortly after the effective date of the relevant equity forward sales agreement, subject to adjustments for accrued interest, the forward purchasers’ stock borrowing costs in excess of a certain threshold specified in the equity forward sales agreement and certain fixed price reductions for expected dividends on our common stock during the term of the equity forward sales agreement. Our unsettled equity forward sales agreements are accounted for as equity instruments. Refer to “Note 15 – Earnings Per Share.”

Dividends

During the six months ended June 30, 2026, we declared a dividend of $0.52 per share of our common stock in each of the first and second quarters. In order to continue to qualify as a REIT, we must make annual distributions to our stockholders of at least 90% of our REIT taxable income (excluding net capital gain). In addition, we will be subject to income tax at the regular corporate rate to the extent we distribute less than 100% of our REIT taxable income, including any net capital gains. We intend to pay dividends greater than 100% of our taxable income, after the use of any net operating loss carryforwards, for 2026.

57

We expect that our cash flows will exceed our REIT taxable income due to depreciation and other non-cash deductions in computing REIT taxable income and that we will be able to satisfy the 90% distribution requirement. However, from time to time, we may not have sufficient cash on hand or other liquid assets to meet this requirement or we may decide to retain cash or distribute such greater amount as may be necessary to avoid income and excise taxation. If we do not have sufficient cash on hand or other liquid assets to enable us to satisfy the 90% distribution requirement, or if we desire to retain cash, we may borrow funds, issue additional equity securities, pay taxable stock dividends, if possible, distribute other property or securities or engage in a transaction intended to enable us to meet the REIT distribution requirements or any combination of the foregoing.

Capital Expenditures

From time to time, we engage in development and redevelopment activities within our reportable business segments and through our investments in unconsolidated entities. For example, we are party to certain agreements that commit us to develop properties funded through capital that we and, in certain circumstances, our joint venture partners provide. In addition, from time to time, we engage in redevelopment projects with respect to our existing senior housing communities, outpatient medical buildings and research centers to maximize the value, increase NOI, maintain a market-competitive position, achieve property stabilization or change the primary use of the property.

The terms of our triple-net leases generally obligate our tenants to pay all capital expenditures necessary to maintain and improve our triple-net leased properties. However, from time to time, we may fund the capital expenditures for our triple-net leased properties through loans or advances to the tenants, which may increase the amount of rent payable with respect to the properties in certain cases. We may also fund capital expenditures for which we may become responsible upon expiration of our triple-net leases or in the event that our tenants are unable or unwilling to meet their obligations under those leases.

We expect that these liquidity needs generally will be satisfied by a combination of the following: cash flows from operations, cash on hand, debt assumptions and financings (including secured financings), issuances of debt and equity securities, dispositions of assets (in whole or in part through joint venture arrangements) and borrowings under our revolving credit facilities and commercial paper program.

To the extent that unanticipated capital expenditure needs arise or significant borrowings are required, our liquidity may be affected adversely. Our ability to borrow additional funds may be restricted in certain circumstances by the terms of the instruments governing our outstanding indebtedness.

Cash Flows     
    
The following table sets forth our sources and uses of cash flows for the six months ended June 30, 2026 and 2025 (dollars in thousands):
 
For the Six Months Ended June 30,
Change
 
2026
2025
$
%
Cash, cash equivalents and restricted cash at beginning of period
$
786,137 
$
957,233 
$
(171,096)
(17.9)
%
Net cash provided by operating activities
951,156 
796,482 
154,674 
19.4 
Net cash used in investing activities
(3,019,305)
(1,088,164)
(1,931,141)
(177.5)
Net cash provided by financing activities
1,507,587 
7,830 
1,499,757 
nm
Effect of foreign currency translation
(1,758)
3,376 
(5,134)
(152.1)
Cash, cash equivalents and restricted cash at end of period
$
223,817 
$
676,757 
$
(452,940)
(66.9)
______________________________
nm - not meaningful

58

Cash Flows from Operating Activities
    
Cash flows from operating activities increased $154.7 million during the six months ended June 30, 2026 compared to the same period in 2025 primarily due to growth in our SHOP business.

Cash Flows from Investing Activities    

Net cash used in investing activities increased $1.9 billion during the six months ended June 30, 2026 compared to the same period in 2025 primarily due to a $1.5 billion increase from higher real estate investments in our SHOP business, $300.9 million increase in loan investments, $96.4 million decrease in proceeds from dispositions and $65.0 million increase in aggregate redevelopment and development projects and other capital expenditures.

Cash Flows from Financing Activities
    
Net cash provided by financing activities increased $1.5 billion during the six months ended June 30, 2026 compared to the same period in 2025 primarily due to a $1.5 billion increase in proceeds from common stock issuances, $304.5 million increase in proceeds from debt and $265.0 million increase in net proceeds from commercial paper, partially offset by $469.3 million increase in debt repayment.

Off-Balance Sheet Arrangements

We own interests in certain unconsolidated entities as described in “Note 7 – Investments in Unconsolidated Entities.” Except in limited circumstances, our risk of loss is limited to our investment in the entities and any outstanding loans receivable. Further, we use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. Finally, as of June 30, 2026, we had $28.9 million outstanding letters of credit obligations.

Commitments and Contingencies

Guarantor and Issuer Information - Registered Senior Notes

Ventas, Inc. has fully and unconditionally guaranteed the obligation to pay principal and interest with respect to the outstanding senior notes issued by our 100% owned subsidiary, VRLP, that were issued in transactions registered under the Securities Act of 1933. No other Ventas entities are issuers or guarantors of debt securities registered under the Securities Act.

Under certain circumstances, contractual and legal restrictions, including those contained in the instruments governing our subsidiaries’ outstanding mortgage indebtedness, may restrict our ability to obtain cash from our subsidiaries for the purpose of meeting our debt service obligations, including VRLP’s payment obligations and our payment guarantees with respect to VRLP’s registered senior notes.

As of June 30, 2026, VRLP was a direct, wholly owned subsidiary of Ventas, Inc. Excluding investments in subsidiaries, the assets, liabilities and results of operations of VRLP and Ventas, Inc., on a combined basis, were not material to the consolidated financial position or consolidated results of operations of Ventas. Therefore, in accordance with Rule 13-01 of Regulation S-X, we have elected to exclude summarized financial information for the issuer and guarantor of our registered senior notes.
59

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The following discussion of our exposure to various market risks contains forward-looking statements that involve risks and uncertainties. These projected results have been prepared utilizing certain assumptions considered reasonable in light of information currently available to us. Nevertheless, because of the inherent unpredictability of interest rates and other factors, actual results could differ materially from those projected in such forward-looking information.

Market Risk

We are primarily exposed to market risk related to changes in interest rates with respect to borrowings under our unsecured revolving credit facility, our unsecured term loans and our commercial paper program, certain of our mortgage loans that are variable rate obligations, mortgage loans receivable that bear interest at variable rates and available for sale securities. These market risks result primarily from changes in benchmark interest rates. To manage these risks, we continuously monitor our level of variable rate debt with respect to total debt and other factors, including our assessment of current and future economic conditions. See “Risk Factors—We are exposed to increases in interest rates, which could reduce our profitability and adversely impact our ability to refinance existing debt, sell assets or engage in acquisition, investment, development and redevelopment activity, and our decision to hedge against interest rate risk might not be effective” included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.

60

The table below sets forth certain information with respect to our debt, excluding premiums and discounts (dollars in thousands):
As of June 30, 2026
As of December 31, 2025
As of June 30, 2025
Balance:
 
 
 
Fixed rate:
 
 
 
Senior notes/Exchangeable senior notes
$
8,350,372 
$
9,761,830 
$
9,274,518 
Unsecured term loans
— 
— 
— 
Mortgage loans and other
2,487,472 
2,202,886 
2,659,357 
Subtotal fixed rate
10,837,844 
11,964,716 
11,933,875 
Variable rate:
Unsecured revolving credit facility
— 
— 
1,374 
Unsecured term loans
1,250,000 
700,000 
700,000 
Commercial paper notes
265,000 
— 
— 
Mortgage loans and other
415,266 
438,911 
519,625 
Subtotal variable rate
1,930,266 
1,138,911 
1,220,999 
Total
$
12,768,110 
$
13,103,627 
$
13,154,874 
Percentage of total debt:
 
 
 
Fixed rate:
 
 
 
Senior notes/Exchangeable senior notes
65.4 
%
74.5 
%
70.5 
%
Unsecured term loans
— 
— 
— 
Mortgage loans and other
19.5 
16.8 
20.2 
Variable rate:
Unsecured revolving credit facility
— 
— 
— 
Unsecured term loans
9.8 
5.3 
5.3 
Commercial paper notes
2.1 
— 
— 
Mortgage loans and other
3.2 
3.4 
4.0 
Total
100.0 
%
100.0 
%
100.0 
%
Weighted average interest rate at end of period:
 
 
 
Fixed rate:
 
 
 
Senior notes/Exchangeable senior notes
4.3 
%
4.3 
%
4.2 
%
Unsecured term loans
— 
— 
— 
Mortgage loans and other
4.6 
4.4 
4.3 
Variable rate:
Unsecured revolving credit facility
— 
— 
5.0 
Unsecured term loans
4.5 
4.7 
5.3 
Commercial paper notes
3.9 
— 
— 
Mortgage loans and other
5.2 
4.9 
4.6 
Total
4.4 
4.3 
4.3 

The variable rate debt as of June 30, 2026 in the table above reflects, in part, the effect of $74.4 million notional amount of interest rate swaps with maturities in March 2027, that effectively convert fixed rate debt to variable rate debt. In addition, the fixed rate debt as of June 30, 2026 in the table above reflects, in part, the effect of $125.1 million and C$587.6 million ($414.0 million) notional amount of interest rate swaps with maturities ranging from June 2027 to April 2031, in each case, that effectively convert variable rate debt to fixed rate debt. See “Note 10 – Senior Notes Payable and Other Debt” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2025.
61


The increase in our outstanding variable rate debt at June 30, 2026 compared to December 31, 2025 was primarily attributable to a $550.0 million term loan draw and an increase of $265.0 million in commercial paper notes outstanding.

The decrease in our outstanding fixed rate debt at June 30, 2026 compared to December 31, 2025 was primarily attributable to the repayment of senior notes.

Assuming a 100 basis point increase in the weighted average interest rate related to our consolidated variable rate debt and assuming no change in our consolidated variable rate debt outstanding as of June 30, 2026 of $1.9 billion, interest expense on an annualized basis would increase by approximately $19.3 million, or approximately $0.04 per diluted common share.

As of June 30, 2026 and December 31, 2025, our joint venture partners’ aggregate share of total consolidated debt was $335.9 million and $328.2 million, respectively, with respect to certain properties we owned through consolidated joint ventures.

Total consolidated debt does not include our portion of unconsolidated debt related to investments in unconsolidated real estate entities, which was $755.8 million and $732.5 million as of June 30, 2026 and December 31, 2025, respectively.

    The fair value of our fixed rate debt is based on current market interest rates at which we could obtain similar borrowings. Increases in market interest rates typically result in a decrease in the fair value of fixed rate debt while decreases in market interest rates typically result in an increase in the fair value of fixed rate date. While changes in market interest rates affect the fair value of our fixed rate debt, these changes do not affect the interest expense associated with our fixed rate debt. Therefore, interest rate risk does not have a significant impact on our fixed rate debt obligations until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could be adversely affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs.

To highlight the sensitivity of our fixed rate debt to changes in interest rates, the following summary shows the effects of a hypothetical instantaneous change of 100 basis points in interest rates (dollars in thousands):
As of June 30, 2026
As of December 31, 2025
Gross book value
$
10,837,844 
$
11,964,716 
Fair value
10,674,965 
12,290,096 
Fair value reflecting change in interest rates:
 
 -100 basis points
11,127,744 
12,826,536 
 +100 basis points
10,257,251 
11,859,768 

As of June 30, 2026 and December 31, 2025, the fair value of our secured and non-mortgage loans receivable, based on our estimates of currently prevailing rates for comparable loans, was $462.4 million and $166.8 million, respectively. See “Note 6 – Loans Receivable and Investments” and “Note 11 – Fair Values of Financial Instruments” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

As a result of our Canadian and United Kingdom operations, we are subject to fluctuations in certain foreign currency exchange rates that may, from time to time, affect our financial condition and operating performance. Based solely on our results for the six months ended June 30, 2026 (including the impact of existing hedging arrangements), if the value of the U.S. dollar relative to the British pound and Canadian dollar were to increase or decrease by one standard deviation compared to the average exchange rate during the year, our Net Income and Normalized FFO for the six months ended June 30, 2026 would decrease or increase by less than $0.01 per diluted common share. We will continue to mitigate these risks through a layered approach to hedging and continual assessment of our foreign operational capital structure. Nevertheless, we cannot assure you that any such fluctuations will not have a significant effect on our earnings.
62


ITEM 4.    CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2026. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective as of June 30, 2026, at the reasonable assurance level.

Internal Control Over Financial Reporting    
 
There have been no changes in our internal controls over financial reporting during the second quarter of 2026 (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

    
63

PART II—OTHER INFORMATION

ITEM 1.        LEGAL PROCEEDINGS

The information contained in “Note 12 – Commitments and Contingencies” of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference into this Item 1. Except as set forth therein, there have been no new material legal proceedings and no material developments in the legal proceedings reported in our 2025 Annual Report.

ITEM 1A.        RISK FACTORS

We face a number of risks and uncertainties. In addition to the other information in this Quarterly Report on Form 10-Q and our other filings with the SEC, readers should consider carefully the risk factors discussed in "Part I, Item 1A. Risk Factors" in our 2025 Annual Report. If any of the risks described in our 2025 Annual Report or such other risks actually occur, our business, results of operations or financial condition could be materially adversely affected.

ITEM 2.        UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

We do not have a publicly announced repurchase plan or program in effect. The table below summarizes repurchases of our common stock made during the quarter ended June 30, 2026:

Number of Shares Repurchased (1)
Average Price Per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number (or Approximate Dollar Value) of Shares that May Yet be Purchased Under the Plans or Programs
April 1 through April 30
43,333 
$
83.27 
— 
— 
May 1 through May 31
30,225 
87.41 
— 
— 
June 1 through June 30
51 
82.02 
— 
— 
Total
73,609 
$
84.97 
— 
— 
______________________________
(1)Repurchases represent shares withheld to pay taxes on the vesting of restricted stock and restricted stock units (including time-based and performance-based awards) and/or to pay taxes on the exercise price upon the exercise of stock options, granted to employees. The value of the shares withheld is the closing price of our common stock on the date the vesting or exercise occurred (or, if not a trading day, the immediately preceding trading day) or the fair market value of our common stock at the time of the exercise, as the case may be.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

64

ITEM 5. OTHER INFORMATION

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

During the three months ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).
65

ITEM 6. EXHIBITS

Exhibit Number
Description of Document
Second Amended and Restated Agreement of Limited Partnership of Ventas Realty, Limited Partnership
Separation Agreement, dated May 12, 2026, between Ventas, Inc. and Peter J. Bulgarelli., Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc.
List of Guarantors and Issuers of Guaranteed Securities.
Certification of Debra A. Cafaro, Chairman and Chief Executive Officer, pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.
Certification of Robert F. Probst, Executive Vice President and Chief Financial Officer, pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.
Certification of Debra A. Cafaro, Chairman and Chief Executive Officer, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350.
Certification of Robert F. Probst, Executive Vice President and Chief Financial Officer, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350.
101
The following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026, formatted in XBRL (Inline Extensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Equity, (v) the Consolidated Statements of Cash Flows and (vi) Notes to the Consolidated Financial Statements.
104
Cover Page Interactive Data File (formatted as inline XBRL).
______________________________
*    Management contract or compensatory plan or arrangement.
+    This exhibit will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

66

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 30, 2026

VENTAS, INC.
By:
/s/ DEBRA A. CAFARO
Debra A. Cafaro
 Chairman and Chief Executive Officer
By:
/s/ ROBERT F. PROBST
Robert F. Probst
Executive Vice President and Chief Financial Officer
67

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-10.1 SECOND AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP

EX-10.2 SEPARATION AGREEMENT

EX-22 GUARANTOR AND ISSUER LISTING

EX-31.1 SECTION 302 CEO CERTIFICATION

EX-31.2 SECTION 302 CFO CERTIFICATION

EX-32.1 SECTION 906 CEO CERTIFICATION

EX-32.2 SECTION 906 CFO CERTIFICATION

XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: R48.htm

IDEA: R49.htm

IDEA: R50.htm

IDEA: R51.htm

IDEA: R52.htm

IDEA: R53.htm

IDEA: R54.htm

IDEA: R55.htm

IDEA: R56.htm

IDEA: R57.htm

IDEA: R58.htm

IDEA: R59.htm

IDEA: R60.htm

IDEA: R61.htm

IDEA: R62.htm

IDEA: R63.htm

IDEA: R64.htm

IDEA: R65.htm

IDEA: R66.htm

IDEA: R67.htm

IDEA: R68.htm

IDEA: R69.htm

IDEA: R70.htm

IDEA: R71.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: vtr-20260630_htm.xml